Publications
  1. Osborne, R. H., Hopper, J. L., Kirk, J. A., Chenevix-Trench, G., Thorne, H. J., and Sambrook, J. F. Kconfab: A Research Resource of Australasian Breast Cancer Families. Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer. Med J Aust, 172 (2000), 463-4. [Pubmed Link]
  2. Butow, P. N., Hiller, J. E., Price, M. A., Thackway, S. V., Kricker, A., and Tennant, C. C. Epidemiological Evidence for a Relationship between Life Events, Coping Style, and Personality Factors in the Development of Breast Cancer. J Psychosom Res, 49 (2000), 169-81. [Pubmed Link]
  3. Marsh, A., Spurdle, A. B., Turner, B. C., Fereday, S., Thorne, H., Pupo, G. M., Mann, G. J., Hopper, J. L., Sambrook, J. F., and Chenevix-Trench, G. The Intronic G13964c Variant in P53 Is Not a High-Risk Mutation in Familial Breast Cancer in Australia. Breast Cancer Res, 3 (2001), 346-9. [Pubmed Link]
  4. Wang, W. W., Spurdle, A. B., Kolachana, P., Bove, B., Modan, B., Ebbers, S. M., Suthers, G., Tucker, M. A., Kaufman, D. J., Doody, M. M., Tarone, R. E., Daly, M., Levavi, H., Pierce, H., Chetrit, A., Yechezkel, G. H., Chenevix-Trench, G., Offit, K., Godwin, A. K., and Struewing, J. P. A Single Nucleotide Polymorphism in the 5' Untranslated Region of Rad51 and Risk of Cancer among Brca1/2 Mutation Carriers. Cancer Epidemiol Biomarkers Prev, 10 (2001), 955-60. [Pubmed Link]
  5. Thompson, D., Szabo, C. I., Mangion, J., Oldenburg, R. A., Odefrey, F., Seal, S., Barfoot, R., Kroeze-Jansema, K., Teare, D., Rahman, N., Renard, H., Mann, G., Hopper, J. L., Buys, S. S., Andrulis, I. L., Senie, R., Daly, M. B., West, D., Ostrander, E. A., Offit, K., Peretz, T., Osorio, A., Benitez, J., Nathanson, K. L., Sinilnikova, O. M., Olah, E., Bignon, Y. J., Ruiz, P., Badzioch, M. D., Vasen, H. F., Futreal, A. P., Phelan, C. M., Narod, S. A., Lynch, H. T., Ponder, B. A., Eeles, R. A., Meijers-Heijboer, H., Stoppa-Lyonnet, D., Couch, F. J., Eccles, D. M., Evans, D. G., Chang-Claude, J., Lenoir, G., Weber, B. L., Devilee, P., Easton, D. F., Goldgar, D. E., and Stratton, M. R. Evaluation of Linkage of Breast Cancer to the Putative Brca3 Locus on Chromosome 13q21 in 128 Multiple Case Families from the Breast Cancer Linkage Consortium. Proc Natl Acad Sci U S A, 99 (2002), 827-31. [Pubmed Link]
  6. Chenevix-Trench, G., Spurdle, A. B., Gatei, M., Kelly, H., Marsh, A., Chen, X., Donn, K., Cummings, M., Nyholt, D., Jenkins, M. A., Scott, C., Pupo, G. M., Dork, T., Bendix, R., Kirk, J., Tucker, K., McCredie, M. R., Hopper, J. L., Sambrook, J., Mann, G. J., and Khanna, K. K. Dominant Negative Atm Mutations in Breast Cancer Families. J Natl Cancer Inst, 94 (2002), 205-15. [Pubmed Link]
  7. Scott, C. L., Jenkins, M. A., Southey, M. C., Davis, T. A., Leary, J. A., Easton, D. F., Phillips, K. A., and Hopper, J. L. Average Age-Specific Cumulative Risk of Breast Cancer According to Type and Site of Germline Mutations in Brca1 and Brca2 Estimated from Multiple-Case Breast Cancer Families Attending Australian Family Cancer Clinics. Hum Genet, 112 (2003), 542-51. [Pubmed Link]
  8. Scott, C. I., Iorgulescu, D. G., Thorne, H. J., Henderson, M. A., and Phillips, K. A. Clinical, Pathological and Genetic Features of Women at High Familial Risk of Breast Cancer Undergoing Prophylactic Mastectomy. Clin Genet, 64 (2003), 111-21. [Pubmed Link]
  9. Southey, M. C., Tesoriero, A., Young, M. A., Holloway, A. J., Jenkins, M. A., Whitty, J., Misfud, S., kConFab, McLachlan, S. A., Venter, D. J., and Armes, J. E. A Specific Gfp Expression Assay, Penetrance Estimate, and Histological Assessment for a Putative Splice Site Mutation in Brca1. Hum Mutat, 22 (2003), 86-91. [Pubmed Link]
  10. Meiser, B., Butow, P., Price, M., Bennett, B., Berry, G., and Tucker, K. Attitudes to Prophylactic Surgery and Chemoprevention in Australian Women at Increased Risk for Breast Cancer. J Womens Health (Larchmt), 12 (2003), 769-78. [Pubmed Link]
  11. Lim, J., Macluran, M., Price, M., Bennett, B., and Butow, P. Short- and Long-Term Impact of Receiving Genetic Mutation Results in Women at Increased Risk for Hereditary Breast Cancer. J Genet Couns, 13 (2004), 115-33. [Pubmed Link]
  12. Mote, P. A., Leary, J. A., Avery, K. A., Sandelin, K., Chenevix-Trench, G., Kirk, J. A., and Clarke, C. L. Germ-Line Mutations in Brca1 or Brca2 in the Normal Breast Are Associated with Altered Expression of Estrogen-Responsive Proteins and the Predominance of Progesterone Receptor A. Genes Chromosomes Cancer, 39 (2004), 236-48. [Pubmed Link]
  13. Campbell, I. G., Choong, D., and Chenevix-Trench, G. No Germline Mutations in the Histone Acetyltransferase Gene Ep300 in Brca1 and Brca2 Negative Families with Breast Cancer and Gastric, Pancreatic, or Colorectal Cancer. Breast Cancer Res, 6 (2004), R366-71. [Pubmed Link]
  14. Aghmesheh, M., Nesland, J. M., Kaern, J., Dorum, A., Edwards, L., Byth, K., Friedlander, M., Jackson, P., Tucker, K. M., and Russell, P. J. No Differences in P53 Mutation Frequencies between Brca1-Associated and Sporadic Ovarian Cancers. Gynecol Oncol, 95 (2004), 430-6. [Pubmed Link]
  15. Whittemore, A. S., Balise, R. R., Pharoah, P. D., Dicioccio, R. A., Oakley-Girvan, I., Ramus, S. J., Daly, M., Usinowicz, M. B., Garlinghouse-Jones, K., Ponder, B. A., Buys, S., Senie, R., Andrulis, I., John, E., Hopper, J. L., and Piver, M. S. Oral Contraceptive Use and Ovarian Cancer Risk among Carriers of Brca1 or Brca2 Mutations. Br J Cancer, 91 (2004), 1911-5. [Pubmed Link]
  16. Butow, P., Meiser, B., Price, M., Bennett, B., Tucker, K., Davenport, T., and Hickie, I. Psychological Morbidity in Women at Increased Risk of Developing Breast Cancer: A Controlled Study. Psychooncology, 14 (2005), 196-203. [Pubmed Link]
  17. Phelan, C. M., Dapic, V., Tice, B., Favis, R., Kwan, E., Barany, F., Manoukian, S., Radice, P., van der Luijt, R. B., van Nesselrooij, B. P., Chenevix-Trench, G., kConFab, Caldes, T., de la Hoya, M., Lindquist, S., Tavtigian, S. V., Goldgar, D., Borg, A., Narod, S. A., and Monteiro, A. N. Classification of Brca1 Missense Variants of Unknown Clinical Significance. J Med Genet, 42 (2005), 138-46. [Pubmed Link]
  18. Chenevix-Trench, G., Sinilnikova, O. M., Suthers, G., Pandeya, N., Mazoyer, S., Sambrook, J. F., Goldup, S., Goldgar, D., Lynch, H. T., Lenoir, G. M., and Cheetham, G. Ratio of Male to Female Births in the Offspring of Brca1 and Brca2 Carriers. Fam Cancer, 4 (2005), 73-5. [Pubmed Link]
  19. Phillips, K. A., Butow, P. N., Stewart, A. E., Chang, J. H., Weideman, P. C., Price, M. A., McLachlan, S. A., Lindeman, G. J., McKay, M. J., Friedlander, M. L., and Hopper, J. L. Predictors of Participation in Clinical and Psychosocial Follow-up of the Kconfab Breast Cancer Family Cohort. Fam Cancer, 4 (2005), 105-13. [Pubmed Link]
  20. Aghmesheh, M., Edwards, L., Clarke, C. L., Byth, K., Katzenellenbogen, B. S., Russell, P. J., Friedlander, M., Tucker, K. M., and de Fazio, A. Expression of Steroid Hormone Receptors in Brca1-Associated Ovarian Carcinomas. Gynecol Oncol, 97 (2005), 16-25. [Pubmed Link]
  21. Spurdle, A. B., Antoniou, A. C., Duffy, D. L., Pandeya, N., Kelemen, L., Chen, X., Peock, S., Cook, M. R., Smith, P. L., Purdie, D. M., Newman, B., Dite, G. S., Apicella, C., Southey, M. C., Giles, G. G., Hopper, J. L., Chenevix-Trench, G., and Easton, D. F. The Androgen Receptor Cag Repeat Polymorphism and Modification of Breast Cancer Risk in Brca1 and Brca2 Mutation Carriers. Breast Cancer Res, 7 (2005), R176-83. [Pubmed Link]
  22. Jekimovs, C. R., Chen, X., Arnold, J., Gatei, M., Richard, D. J., Spurdle, A. B., Khanna, K. K., and Chenevix-Trench, G. Low Frequency of Chek2 1100delc Allele in Australian Multiple-Case Breast Cancer Families: Functional Analysis in Heterozygous Individuals. Br J Cancer, 92 (2005), 784-90. [Pubmed Link]
  23. Woodward, A. M., Davis, T. A., Silva, A. G., Kirk, J. A., and Leary, J. A. Large Genomic Rearrangements of Both Brca2 and Brca1 Are a Feature of the Inherited Breast/Ovarian Cancer Phenotype in Selected Families. J Med Genet, 42 (2005), e31. [Pubmed Link]
  24. Thompson, D., Antoniou, A. C., Jenkins, M., Marsh, A., Chen, X., Wayne, T., Tesoriero, A., Milne, R., Spurdle, A., Thorstenson, Y., Southey, M., Giles, G. G., Khanna, K. K., Sambrook, J., Oefner, P., Goldgar, D., Hopper, J. L., Easton, D., and Chenevix-Trench, G. Two Atm Variants and Breast Cancer Risk. Hum Mutat, 25 (2005), 594-5. [Pubmed Link]
  25. Tesoriero, A. A., Wong, E. M., Jenkins, M. A., Hopper, J. L., Brown, M. A., Chenevix-Trench, G., Spurdle, A. B., and Southey, M. C. Molecular Characterization and Cancer Risk Associated with Brca1 and Brca2 Splice Site Variants Identified in Multiple-Case Breast Cancer Families. Hum Mutat, 26 (2005), 495. [Pubmed Link]
  26. Wardrop, S. L., and Brown, M. A. Identification of Two Evolutionarily Conserved and Functional Regulatory Elements in Intron 2 of the Human Brca1 Gene. Genomics, 86 (2005), 316-28. [Pubmed Link]
  27. Lewis, A. G., Flanagan, J., Marsh, A., Pupo, G. M., Mann, G., Spurdle, A. B., Lindeman, G. J., Visvader, J. E., Brown, M. A., and Chenevix-Trench, G. Mutation Analysis of Fancd2, Brip1/Bach1, Lmo4 and Sfn in Familial Breast Cancer. Breast Cancer Res, 7 (2005), R1005-16. [Pubmed Link]
  28. Lovelock, P. K., Healey, S., Au, W., Sum, E. Y., Tesoriero, A., Wong, E. M., Hinson, S., Brinkworth, R., Bekessy, A., Diez, O., Izatt, L., Solomon, E., Jenkins, M., Renard, H., Hopper, J., Waring, P., Tavtigian, S. V., Goldgar, D., Lindeman, G. J., Visvader, J. E., Couch, F. J., Henderson, B. R., Southey, M., Chenevix-Trench, G., Spurdle, A. B., and Brown, M. A. Genetic, Functional, and Histopathological Evaluation of Two C-Terminal Brca1 Missense Variants. J Med Genet, 43 (2006), 74-83. [Pubmed Link]
  29. Spurdle, A. B., Antoniou, A. C., Kelemen, L., Holland, H., Peock, S., Cook, M. R., Smith, P. L., Greene, M. H., Simard, J., Plourde, M., Southey, M. C., Godwin, A. K., Beck, J., Miron, A., Daly, M. B., Santella, R. M., Hopper, J. L., John, E. M., Andrulis, I. L., Durocher, F., Struewing, J. P., Easton, D. F., and Chenevix-Trench, G. The Aib1 Polyglutamine Repeat Does Not Modify Breast Cancer Risk in Brca1 and Brca2 Mutation Carriers. Cancer Epidemiol Biomarkers Prev, 15 (2006), 76-9. [Pubmed Link]
  30. Chenevix-Trench, G., Healey, S., Lakhani, S., Waring, P., Cummings, M., Brinkworth, R., Deffenbaugh, A. M., Burbidge, L. A., Pruss, D., Judkins, T., Scholl, T., Bekessy, A., Marsh, A., Lovelock, P., Wong, M., Tesoriero, A., Renard, H., Southey, M., Hopper, J. L., Yannoukakos, K., Brown, M., Easton, D., Tavtigian, S. V., Goldgar, D., and Spurdle, A. B. Genetic and Histopathologic Evaluation of Brca1 and Brca2 DNA Sequence Variants of Unknown Clinical Significance. Cancer Res, 66 (2006), 2019-27. [Pubmed Link]
  31. Mann, G. J., Thorne, H., Balleine, R. L., Butow, P. N., Clarke, C. L., Edkins, E., Evans, G. M., Fereday, S., Haan, E., Gattas, M., Giles, G. G., Goldblatt, J., Hopper, J. L., Kirk, J., Leary, J. A., Lindeman, G., Niedermayr, E., Phillips, K. A., Picken, S., Pupo, G. M., Saunders, C., Scott, C. L., Spurdle, A. B., Suthers, G., Tucker, K., and Chenevix-Trench, G. Analysis of Cancer Risk and Brca1 and Brca2 Mutation Prevalence in the Kconfab Familial Breast Cancer Resource. Breast Cancer Res, 8 (2006), R12. [Pubmed Link]
  32. Farshid, G., Balleine, R. L., Cummings, M., and Waring, P. Morphology of Breast Cancer as a Means of Triage of Patients for Brca1 Genetic Testing. Am J Surg Pathol, 30 (2006), 1357-66. [Pubmed Link]
  33. Smith, P., McGuffog, L., Easton, D. F., Mann, G. J., Pupo, G. M., Newman, B., Chenevix-Trench, G., Szabo, C., Southey, M., Renard, H., Odefrey, F., Lynch, H., Stoppa-Lyonnet, D., Couch, F., Hopper, J. L., Giles, G. G., McCredie, M. R., Buys, S., Andrulis, I., Senie, R., Goldgar, D. E., Oldenburg, R., Kroeze-Jansema, K., Kraan, J., Meijers-Heijboer, H., Klijn, J. G., van Asperen, C., van Leeuwen, I., Vasen, H. F., Cornelisse, C. J., Devilee, P., Baskcomb, L., Seal, S., Barfoot, R., Mangion, J., Hall, A., Edkins, S., Rapley, E., Wooster, R., Chang-Claude, J., Eccles, D., Evans, D. G., Futreal, P. A., Nathanson, K. L., Weber, B. L., Rahman, N., and Stratton, M. R. A Genome Wide Linkage Search for Breast Cancer Susceptibility Genes. Genes Chromosomes Cancer, 45 (2006), 646-55. [Pubmed Link]
  34. Balleine, R. L., Murali, R., Bilous, A. M., Farshid, G., Waring, P., Provan, P., Byth, K., Thorne, H., and Kirk, J. A. Histopathological Features of Breast Cancer in Carriers of Atm Gene Variants. Histopathology, 49 (2006), 523-32. [Pubmed Link]
  35. Aghmesheh, M., Suo, Z., Friedlander, M., Nesland, J. M., Kaern, J., Stewart, M., Kconfab, Dorum, A., Tucker, K. M., and Buckley, M. F. Chromosome 2q24.2 Is Lost in Sporadic but Not in Brca1-Associated Ovarian Carcinomas. Pathology, 38 (2006), 145-51. [Pubmed Link]
  36. Lose, F., Lovelock, P., Chenevix-Trench, G., Mann, G. J., Pupo, G. M., and Spurdle, A. B. Variation in the Rad51 Gene and Familial Breast Cancer. Breast Cancer Res, 8 (2006), R26. [Pubmed Link]
  37. Phillips, K. A., Jenkins, M. A., Lindeman, G. J., McLachlan, S. A., McKinley, J. M., Weideman, P. C., Hopper, J. L., and Friedlander, M. L. Risk-Reducing Surgery, Screening and Chemoprevention Practices of Brca1 and Brca2 Mutation Carriers: A Prospective Cohort Study. Clin Genet, 70 (2006), 198-206. [Pubmed Link]
  38. Waddell, N., Jonnalagadda, J., Marsh, A., Grist, S., Jenkins, M., Hobson, K., Taylor, M., Lindeman, G. J., Tavtigian, S. V., Suthers, G., Goldgar, D., Oefner, P. J., Taylor, D., Grimmond, S., Khanna, K. K., and Chenevix-Trench, G. Characterization of the Breast Cancer Associated Atm 7271t>G (V2424g) Mutation by Gene Expression Profiling. Genes Chromosomes Cancer, 45 (2006), 1169-81. [Pubmed Link]
  39. McGuire, V., John, E. M., Felberg, A., Haile, R. W., Boyd, N. F., Thomas, D. C., Jenkins, M. A., Milne, R. L., Daly, M. B., Ward, J., Terry, M. B., Andrulis, I. L., Knight, J. A., Godwin, A. K., Giles, G. G., Southey, M., West, D. W., Hopper, J. L., and Whittemore, A. S. No Increased Risk of Breast Cancer Associated with Alcohol Consumption among Carriers of Brca1 and Brca2 Mutations Ages <50 Years. Cancer Epidemiol Biomarkers Prev, 15 (2006), 1565-7. [Pubmed Link]
  40. Kang, H. H., Williams, R., Leary, J., Ringland, C., Kirk, J., and Ward, R. Evaluation of Models to Predict Brca Germline Mutations. Br J Cancer, 95 (2006), 914-20. [Pubmed Link]
  41. Haile, R. W., Thomas, D. C., McGuire, V., Felberg, A., John, E. M., Milne, R. L., Hopper, J. L., Jenkins, M. A., Levine, A. J., Daly, M. M., Buys, S. S., Senie, R. T., Andrulis, I. L., Knight, J. A., Godwin, A. K., Southey, M., McCredie, M. R., Giles, G. G., Andrews, L., Tucker, K., Miron, A., Apicella, C., Tesoriero, A., Bane, A., Pike, M. C., and Whittemore, A. S. Brca1 and Brca2 Mutation Carriers, Oral Contraceptive Use, and Breast Cancer before Age 50. Cancer Epidemiol Biomarkers Prev, 15 (2006), 1863-70. [Pubmed Link]
  42. Lovelock, P. K., Wong, E. M., Sprung, C. N., Marsh, A., Hobson, K., French, J. D., Southey, M., Sculley, T., Pandeya, N., Brown, M. A., Chenevix-Trench, G., Spurdle, A. B., and McKay, M. J. Prediction of Brca1 and Brca2 Mutation Status Using Post-Irradiation Assays of Lymphoblastoid Cell Lines Is Compromised by Inter-Cell-Line Phenotypic Variability. Breast Cancer Res Treat, 104 (2007), 257-66. [Pubmed Link]
  43. Marsh, A., Healey, S., Lewis, A., Spurdle, A. B., Kedda, M. A., Khanna, K. K., Mann, G. J., Pupo, G. M., Lakhani, S. R., and Chenevix-Trench, G. Mutation Analysis of Five Candidate Genes in Familial Breast Cancer. Breast Cancer Res Treat, 105 (2007), 377-89. [Pubmed Link]
  44. Easton, D. F., Pooley, K. A., Dunning, A. M., Pharoah, P. D., Thompson, D., Ballinger, D. G., Struewing, J. P., Morrison, J., Field, H., Luben, R., Wareham, N., Ahmed, S., Healey, C. S., Bowman, R., Meyer, K. B., Haiman, C. A., Kolonel, L. K., Henderson, B. E., Le Marchand, L., Brennan, P., Sangrajrang, S., Gaborieau, V., Odefrey, F., Shen, C. Y., Wu, P. E., Wang, H. C., Eccles, D., Evans, D. G., Peto, J., Fletcher, O., Johnson, N., Seal, S., Stratton, M. R., Rahman, N., Chenevix-Trench, G., Bojesen, S. E., Nordestgaard, B. G., Axelsson, C. K., Garcia-Closas, M., Brinton, L., Chanock, S., Lissowska, J., Peplonska, B., Nevanlinna, H., Fagerholm, R., Eerola, H., Kang, D., Yoo, K. Y., Noh, D. Y., Ahn, S. H., Hunter, D. J., Hankinson, S. E., Cox, D. G., Hall, P., Wedren, S., Liu, J., Low, Y. L., Bogdanova, N., Schurmann, P., Dork, T., Tollenaar, R. A., Jacobi, C. E., Devilee, P., Klijn, J. G., Sigurdson, A. J., Doody, M. M., Alexander, B. H., Zhang, J., Cox, A., Brock, I. W., MacPherson, G., Reed, M. W., Couch, F. J., Goode, E. L., Olson, J. E., Meijers-Heijboer, H., van den Ouweland, A., Uitterlinden, A., Rivadeneira, F., Milne, R. L., Ribas, G., Gonzalez-Neira, A., Benitez, J., Hopper, J. L., McCredie, M., Southey, M., Giles, G. G., Schroen, C., Justenhoven, C., Brauch, H., Hamann, U., Ko, Y. D., Spurdle, A. B., Beesley, J., Chen, X., Mannermaa, A., Kosma, V. M., Kataja, V., Hartikainen, J., Day, N. E., Cox, D. R., and Ponder, B. A. Genome-Wide Association Study Identifies Novel Breast Cancer Susceptibility Loci. Nature, 447 (2007), 1087-93. [Pubmed Link]
  45. Couch, F. J., Sinilnikova, O., Vierkant, R. A., Pankratz, V. S., Fredericksen, Z. S., Stoppa-Lyonnet, D., Coupier, I., Hughes, D., Hardouin, A., Berthet, P., Peock, S., Cook, M., Baynes, C., Hodgson, S., Morrison, P. J., Porteous, M. E., Jakubowska, A., Lubinski, J., Gronwald, J., Spurdle, A. B., Schmutzler, R., Versmold, B., Engel, C., Meindl, A., Sutter, C., Horst, J., Schaefer, D., Offit, K., Kirchhoff, T., Andrulis, I. L., Ilyushik, E., Glendon, G., Devilee, P., Vreeswijk, M. P., Vasen, H. F., Borg, A., Backenhorn, K., Struewing, J. P., Greene, M. H., Neuhausen, S. L., Rebbeck, T. R., Nathanson, K., Domchek, S., Wagner, T., Garber, J. E., Szabo, C., Zikan, M., Foretova, L., Olson, J. E., Sellers, T. A., Lindor, N., Nevanlinna, H., Tommiska, J., Aittomaki, K., Hamann, U., Rashid, M. U., Torres, D., Simard, J., Durocher, F., Guenard, F., Lynch, H. T., Isaacs, C., Weitzel, J., Olopade, O. I., Narod, S., Daly, M. B., Godwin, A. K., Tomlinson, G., Easton, D. F., Chenevix-Trench, G., and Antoniou, A. C. Aurka F31i Polymorphism and Breast Cancer Risk in Brca1 and Brca2 Mutation Carriers: A Consortium of Investigators of Modifiers of Brca1/2 Study. Cancer Epidemiol Biomarkers Prev, 16 (2007), 1416-21. [Pubmed Link]
  46. McKinley, J. M., Weideman, P. C., Jenkins, M. A., Friedlander, M. L., Hopper, J. L., McLachlan, S. A., Lindeman, G. J., and Phillips, K. A. Prostate Screening Uptake in Australian Brca1 and Brca2 Carriers. Hered Cancer Clin Pract, 5 (2007), 161-3. [Pubmed Link]
  47. Antoniou, A. C., Sinilnikova, O. M., Simard, J., Leone, M., Dumont, M., Neuhausen, S. L., Struewing, J. P., Stoppa-Lyonnet, D., Barjhoux, L., Hughes, D. J., Coupier, I., Belotti, M., Lasset, C., Bonadona, V., Bignon, Y. J., Rebbeck, T. R., Wagner, T., Lynch, H. T., Domchek, S. M., Nathanson, K. L., Garber, J. E., Weitzel, J., Narod, S. A., Tomlinson, G., Olopade, O. I., Godwin, A., Isaacs, C., Jakubowska, A., Lubinski, J., Gronwald, J., Gorski, B., Byrski, T., Huzarski, T., Peock, S., Cook, M., Baynes, C., Murray, A., Rogers, M., Daly, P. A., Dorkins, H., Schmutzler, R. K., Versmold, B., Engel, C., Meindl, A., Arnold, N., Niederacher, D., Deissler, H., Spurdle, A. B., Chen, X., Waddell, N., Cloonan, N., Kirchhoff, T., Offit, K., Friedman, E., Kaufmann, B., Laitman, Y., Galore, G., Rennert, G., Lejbkowicz, F., Raskin, L., Andrulis, I. L., Ilyushik, E., Ozcelik, H., Devilee, P., Vreeswijk, M. P., Greene, M. H., Prindiville, S. A., Osorio, A., Benitez, J., Zikan, M., Szabo, C. I., Kilpivaara, O., Nevanlinna, H., Hamann, U., Durocher, F., Arason, A., Couch, F. J., Easton, D. F., and Chenevix-Trench, G. Rad51 135g-->C Modifies Breast Cancer Risk among Brca2 Mutation Carriers: Results from a Combined Analysis of 19 Studies. Am J Hum Genet, 81 (2007), 1186-200. [Pubmed Link]
  48. Cox, A., Dunning, A. M., Garcia-Closas, M., Balasubramanian, S., Reed, M. W., Pooley, K. A., Scollen, S., Baynes, C., Ponder, B. A., Chanock, S., Lissowska, J., Brinton, L., Peplonska, B., Southey, M. C., Hopper, J. L., McCredie, M. R., Giles, G. G., Fletcher, O., Johnson, N., dos Santos Silva, I., Gibson, L., Bojesen, S. E., Nordestgaard, B. G., Axelsson, C. K., Torres, D., Hamann, U., Justenhoven, C., Brauch, H., Chang-Claude, J., Kropp, S., Risch, A., Wang-Gohrke, S., Schurmann, P., Bogdanova, N., Dork, T., Fagerholm, R., Aaltonen, K., Blomqvist, C., Nevanlinna, H., Seal, S., Renwick, A., Stratton, M. R., Rahman, N., Sangrajrang, S., Hughes, D., Odefrey, F., Brennan, P., Spurdle, A. B., Chenevix-Trench, G., Beesley, J., Mannermaa, A., Hartikainen, J., Kataja, V., Kosma, V. M., Couch, F. J., Olson, J. E., Goode, E. L., Broeks, A., Schmidt, M. K., Hogervorst, F. B., Van't Veer, L. J., Kang, D., Yoo, K. Y., Noh, D. Y., Ahn, S. H., Wedren, S., Hall, P., Low, Y. L., Liu, J., Milne, R. L., Ribas, G., Gonzalez-Neira, A., Benitez, J., Sigurdson, A. J., Stredrick, D. L., Alexander, B. H., Struewing, J. P., Pharoah, P. D., and Easton, D. F. A Common Coding Variant in Casp8 Is Associated with Breast Cancer Risk. Nat Genet, 39 (2007), 352-8. [Pubmed Link]
  49. Price, M. A., Butow, P. N., Lo, S. K., and Wilson, J. Predictors of Cancer Worry in Unaffected Women from High Risk Breast Cancer Families: Risk Perception Is Not the Primary Issue. J Genet Couns, 16 (2007), 635-44. [Pubmed Link]
  50. Lovelock, P. K., Spurdle, A. B., Mok, M. T., Farrugia, D. J., Lakhani, S. R., Healey, S., Arnold, S., Buchanan, D., Couch, F. J., Henderson, B. R., Goldgar, D. E., Tavtigian, S. V., Chenevix-Trench, G., and Brown, M. A. Identification of Brca1 Missense Substitutions That Confer Partial Functional Activity: Potential Moderate Risk Variants? Breast Cancer Res, 9 (2007), R82. [Pubmed Link]
  51. Lose, F., Arnold, J., Young, D. B., Brown, C. J., Mann, G. J., Pupo, G. M., Khanna, K. K., Chenevix-Trench, G., and Spurdle, A. B. Bcor-L1 Variation and Breast Cancer. Breast Cancer Res, 9 (2007), R54. [Pubmed Link]
  52. Johnatty, S. E., Spurdle, A. B., Beesley, J., Chen, X., Hopper, J. L., Duffy, D. L., and Chenevix-Trench, G. Progesterone Receptor Polymorphisms and Risk of Breast Cancer: Results from Two Australian Breast Cancer Studies. Breast Cancer Res Treat, 109 (2008), 91-9. [Pubmed Link]
  53. Loughrey, M., Provan, P. J., Byth, K., and Balleine, R. L. Histopathological Features of 'Brcax' Familial Breast Cancers in the Kconfab Resource. Pathology, 40 (2008), 352-8. [Pubmed Link]
  54. Wong, E. M., Tesoriero, A. A., Pupo, G. M., McCredie, M. R., Giles, G. G., Hopper, J. L., Mann, G. J., Goldgar, D. E., and Southey, M. C. Is Msh2 a Breast Cancer Susceptibility Gene? Fam Cancer, 7 (2008), 151-5. [Pubmed Link]
  55. Dawson, S. J., Price, M. A., Jenkins, M. A., McKinley, J. M., Butow, P. N., McLachlan, S. A., Lindeman, G. J., Weideman, P., Friedlander, M. L., Hopper, J. L., and Phillips, K. A. Cancer Risk Management Practices of Noncarriers within Brca1/2 Mutation Positive Families in the Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer. J Clin Oncol, 26 (2008), 225-32. [Pubmed Link]
  56. Registry, B. C. F. Smoking and Risk of Breast Cancer in Carriers of Mutations in Brca1 or Brca2 Aged Less Than 50 Years. Breast Cancer Res Treat, 109 (2008), 67-75. [Pubmed Link]
  57. Spurdle, A. B., Lakhani, S. R., Healey, S., Parry, S., Da Silva, L. M., Brinkworth, R., Hopper, J. L., Brown, M. A., Babikyan, D., Chenevix-Trench, G., Tavtigian, S. V., and Goldgar, D. E. Clinical Classification of Brca1 and Brca2 DNA Sequence Variants: The Value of Cytokeratin Profiles and Evolutionary Analysis--a Report from the Kconfab Investigators. J Clin Oncol, 26 (2008), 1657-63. [Pubmed Link]
  58. Tischkowitz, M., Hamel, N., Carvalho, M. A., Birrane, G., Soni, A., van Beers, E. H., Joosse, S. A., Wong, N., Novak, D., Quenneville, L. A., Grist, S. A., Nederlof, P. M., Goldgar, D. E., Tavtigian, S. V., Monteiro, A. N., Ladias, J. A., and Foulkes, W. D. Pathogenicity of the Brca1 Missense Variant M1775k Is Determined by the Disruption of the Brct Phosphopeptide-Binding Pocket: A Multi-Modal Approach. Eur J Hum Genet, 16 (2008), 820-32. [Pubmed Link]
  59. Walker, L. C., Waddell, N., Ten Haaf, A., Grimmond, S., and Spurdle, A. B. Use of Expression Data and the Cgems Genome-Wide Breast Cancer Association Study to Identify Genes That May Modify Risk in Brca1/2 Mutation Carriers. Breast Cancer Res Treat, 112 (2008), 229-36. [Pubmed Link]
  60. Gorringe, K. L., Choong, D. Y., Lindeman, G. J., Visvader, J. E., and Campbell, I. G. Breast Cancer Risk and the Brca1 Interacting Protein Ctip. Breast Cancer Res Treat, 112 (2008), 351-2. [Pubmed Link]
  61. Frank, B., Wiestler, M., Kropp, S., Hemminki, K., Spurdle, A. B., Sutter, C., Wappenschmidt, B., Chen, X., Beesley, J., Hopper, J. L., Meindl, A., Kiechle, M., Slanger, T., Bugert, P., Schmutzler, R. K., Bartram, C. R., Flesch-Janys, D., Mutschelknauss, E., Ashton, K., Salazar, R., Webb, E., Hamann, U., Brauch, H., Justenhoven, C., Ko, Y. D., Bruning, T., Silva Idos, S., Johnson, N., Pharoah, P. P., Dunning, A. M., Pooley, K. A., Chang-Claude, J., Easton, D. F., Peto, J., Houlston, R., Chenevix-Trench, G., Fletcher, O., and Burwinkel, B. Association of a Common Akap9 Variant with Breast Cancer Risk: A Collaborative Analysis. J Natl Cancer Inst, 100 (2008), 437-42. [Pubmed Link]
  62. Antoniou, A. C., Spurdle, A. B., Sinilnikova, O. M., Healey, S., Pooley, K. A., Schmutzler, R. K., Versmold, B., Engel, C., Meindl, A., Arnold, N., Hofmann, W., Sutter, C., Niederacher, D., Deissler, H., Caldes, T., Kampjarvi, K., Nevanlinna, H., Simard, J., Beesley, J., Chen, X., Neuhausen, S. L., Rebbeck, T. R., Wagner, T., Lynch, H. T., Isaacs, C., Weitzel, J., Ganz, P. A., Daly, M. B., Tomlinson, G., Olopade, O. I., Blum, J. L., Couch, F. J., Peterlongo, P., Manoukian, S., Barile, M., Radice, P., Szabo, C. I., Pereira, L. H., Greene, M. H., Rennert, G., Lejbkowicz, F., Barnett-Griness, O., Andrulis, I. L., Ozcelik, H., Gerdes, A. M., Caligo, M. A., Laitman, Y., Kaufman, B., Milgrom, R., Friedman, E., Domchek, S. M., Nathanson, K. L., Osorio, A., Llort, G., Milne, R. L., Benitez, J., Hamann, U., Hogervorst, F. B., Manders, P., Ligtenberg, M. J., van den Ouweland, A. M., Peock, S., Cook, M., Platte, R., Evans, D. G., Eeles, R., Pichert, G., Chu, C., Eccles, D., Davidson, R., Douglas, F., Godwin, A. K., Barjhoux, L., Mazoyer, S., Sobol, H., Bourdon, V., Eisinger, F., Chompret, A., Capoulade, C., Bressac-de Paillerets, B., Lenoir, G. M., Gauthier-Villars, M., Houdayer, C., Stoppa-Lyonnet, D., Chenevix-Trench, G., and Easton, D. F. Common Breast Cancer-Predisposition Alleles Are Associated with Breast Cancer Risk in Brca1 and Brca2 Mutation Carriers. Am J Hum Genet, 82 (2008), 937-48. [Pubmed Link]
  63. Snell, C., Krypuy, M., Wong, E. M., Loughrey, M. B., and Dobrovic, A. Brca1 Promoter Methylation in Peripheral Blood DNA of Mutation Negative Familial Breast Cancer Patients with a Brca1 Tumour Phenotype. Breast Cancer Res, 10 (2008), R12. [Pubmed Link]
  64. Willems, A. J., Dawson, S. J., Samaratunga, H., De Luca, A., Antill, Y. C., Hopper, J. L., and Thorne, H. J. Loss of Heterozygosity at the Brca2 Locus Detected by Multiplex Ligation-Dependent Probe Amplification Is Common in Prostate Cancers from Men with a Germline Brca2 Mutation. Clin Cancer Res, 14 (2008), 2953-61. [Pubmed Link]
  65. Garcia-Closas, M., Hall, P., Nevanlinna, H., Pooley, K., Morrison, J., Richesson, D. A., Bojesen, S. E., Nordestgaard, B. G., Axelsson, C. K., Arias, J. I., Milne, R. L., Ribas, G., Gonzalez-Neira, A., Benitez, J., Zamora, P., Brauch, H., Justenhoven, C., Hamann, U., Ko, Y. D., Bruening, T., Haas, S., Dork, T., Schurmann, P., Hillemanns, P., Bogdanova, N., Bremer, M., Karstens, J. H., Fagerholm, R., Aaltonen, K., Aittomaki, K., von Smitten, K., Blomqvist, C., Mannermaa, A., Uusitupa, M., Eskelinen, M., Tengstrom, M., Kosma, V. M., Kataja, V., Chenevix-Trench, G., Spurdle, A. B., Beesley, J., Chen, X., Devilee, P., van Asperen, C. J., Jacobi, C. E., Tollenaar, R. A., Huijts, P. E., Klijn, J. G., Chang-Claude, J., Kropp, S., Slanger, T., Flesch-Janys, D., Mutschelknauss, E., Salazar, R., Wang-Gohrke, S., Couch, F., Goode, E. L., Olson, J. E., Vachon, C., Fredericksen, Z. S., Giles, G. G., Baglietto, L., Severi, G., Hopper, J. L., English, D. R., Southey, M. C., Haiman, C. A., Henderson, B. E., Kolonel, L. N., Le Marchand, L., Stram, D. O., Hunter, D. J., Hankinson, S. E., Cox, D. G., Tamimi, R., Kraft, P., Sherman, M. E., Chanock, S. J., Lissowska, J., Brinton, L. A., Peplonska, B., Hooning, M. J., Meijers-Heijboer, H., Collee, J. M., van den Ouweland, A., Uitterlinden, A. G., Liu, J., Lin, L. Y., Yuqing, L., Humphreys, K., Czene, K., Cox, A., Balasubramanian, S. P., Cross, S. S., Reed, M. W., Blows, F., Driver, K., Dunning, A., Tyrer, J., Ponder, B. A., Sangrajrang, S., Brennan, P., McKay, J., Odefrey, F., Gabrieau, V., Sigurdson, A., Doody, M., Struewing, J. P., Alexander, B., Easton, D. F., and Pharoah, P. D. Heterogeneity of Breast Cancer Associations with Five Susceptibility Loci by Clinical and Pathological Characteristics. PLoS Genet, 4 (2008), e1000054. [Pubmed Link]
  66. Waddell, N., Ten Haaf, A., Marsh, A., Johnson, J., Walker, L. C., Gongora, M., Brown, M., Grover, P., Girolami, M., Grimmond, S., Chenevix-Trench, G., and Spurdle, A. B. Brca1 and Brca2 Missense Variants of High and Low Clinical Significance Influence Lymphoblastoid Cell Line Post-Irradiation Gene Expression. PLoS Genet, 4 (2008), e1000080. [Pubmed Link]
  67. Dowty, J. G., Lose, F., Jenkins, M. A., Chang, J. H., Chen, X., Beesley, J., Dite, G. S., Southey, M. C., Byrnes, G. B., Tesoriero, A., Giles, G. G., Hopper, J. L., and Spurdle, A. B. The Rad51d E233g Variant and Breast Cancer Risk: Population-Based and Clinic-Based Family Studies of Australian Women. Breast Cancer Res Treat, 112 (2008), 35-9. [Pubmed Link]
  68. Lose, F., Duffy, D. L., Kay, G. F., Kedda, M. A., and Spurdle, A. B. Skewed X Chromosome Inactivation and Breast and Ovarian Cancer Status: Evidence for X-Linked Modifiers of Brca1. J Natl Cancer Inst, 100 (2008), 1519-29. [Pubmed Link]
  69. Johnatty, S. E., Beesley, J., Chen, X., Hopper, J. L., Southey, M. C., Giles, G. G., Goldgar, D. E., Chenevix-Trench, G., and Spurdle, A. B. The Bard1 Cys557ser Polymorphism and Breast Cancer Risk: An Australian Case-Control and Family Analysis. Breast Cancer Res Treat, 115 (2009), 145-50. [Pubmed Link]
  70. Rebbeck, T. R., Antoniou, A. C., Llopis, T. C., Nevanlinna, H., Aittomaki, K., Simard, J., Spurdle, A. B., Couch, F. J., Pereira, L. H., Greene, M. H., Andrulis, I. L., Pasche, B., Kaklamani, V., Hamann, U., Szabo, C., Peock, S., Cook, M., Harrington, P. A., Donaldson, A., Male, A. M., Gardiner, C. A., Gregory, H., Side, L. E., Robinson, A. C., Emmerson, L., Ellis, I., Peyrat, J. P., Fournier, J., Vennin, P., Adenis, C., Muller, D., Fricker, J. P., Longy, M., Sinilnikova, O. M., Stoppa-Lyonnet, D., Schmutzler, R. K., Versmold, B., Engel, C., Meindl, A., Kast, K., Schaefer, D., Froster, U. G., Chenevix-Trench, G., and Easton, D. F. No Association of Tgfb1 L10p Genotypes and Breast Cancer Risk in Brca1 and Brca2 Mutation Carriers: A Multi-Center Cohort Study. Breast Cancer Res Treat, 115 (2009), 185-92. [Pubmed Link]
  71. Spurdle, A. B., Deans, A. J., Duffy, D., Goldgar, D. E., Chen, X., Beesley, J., Easton, D. F., Antoniou, A. C., Peock, S., Cook, M., Nathanson, K. L., Domchek, S. M., MacArthur, G. A., and Chenevix-Trench, G. No Evidence That Cdkn1b (P27) Polymorphisms Modify Breast Cancer Risk in Brca1 and Brca2 Mutation Carriers. Breast Cancer Res Treat, 115 (2009), 307-13. [Pubmed Link]
  72. Field, K. M., Jenkins, M. A., Friedlander, M. L., McKinley, J. M., Price, M. A., Weideman, P., Keogh, L. A., McLachlan, S. A., Lindeman, G. J., Hopper, J. L., Butow, P. N., and Phillips, K. A. Predictors of the Use of Complementary and Alternative Medicine (Cam) by Women at High Risk for Breast Cancer. Eur J Cancer, 45 (2009), 551-60. [Pubmed Link]
  73. Johnatty, S. E., Couch, F. J., Fredericksen, Z., Tarrell, R., Spurdle, A. B., Beesley, J., Chen, X., Gschwantler-Kaulich, D., Singer, C. F., Fuerhauser, C., Fink-Retter, A., Domchek, S. M., Nathanson, K. L., Pankratz, V. S., Lindor, N. M., Godwin, A. K., Caligo, M. A., Hopper, J., Southey, M. C., Giles, G. G., Justenhoven, C., Brauch, H., Hamann, U., Ko, Y. D., Heikkinen, T., Aaltonen, K., Aittomaki, K., Blomqvist, C., Nevanlinna, H., Hall, P., Czene, K., Liu, J., Peock, S., Cook, M., Platte, R., Gareth Evans, D., Lalloo, F., Eeles, R., Pichert, G., Eccles, D., Davidson, R., Cole, T., Cook, J., Douglas, F., Chu, C., Hodgson, S., Paterson, J., Hogervorst, F. B., Rookus, M. A., Seynaeve, C., Wijnen, J., Vreeswijk, M., Ligtenberg, M., van der Luijt, R. B., van Os, T. A., Gille, H. J., Blok, M. J., Issacs, C., Humphreys, M. K., McGuffog, L., Healey, S., Sinilnikova, O., Antoniou, A. C., Easton, D. F., and Chenevix-Trench, G. No Evidence That Gata3 Rs570613 Snp Modifies Breast Cancer Risk. Breast Cancer Res Treat, 117 (2009), 371-9. [Pubmed Link]
  74. Dunning, A. M., Healey, C. S., Baynes, C., Maia, A. T., Scollen, S., Vega, A., Rodriguez, R., Barbosa-Morais, N. L., Ponder, B. A., Low, Y. L., Bingham, S., Haiman, C. A., Le Marchand, L., Broeks, A., Schmidt, M. K., Hopper, J., Southey, M., Beckmann, M. W., Fasching, P. A., Peto, J., Johnson, N., Bojesen, S. E., Nordestgaard, B., Milne, R. L., Benitez, J., Hamann, U., Ko, Y., Schmutzler, R. K., Burwinkel, B., Schurmann, P., Dork, T., Heikkinen, T., Nevanlinna, H., Lindblom, A., Margolin, S., Mannermaa, A., Kosma, V. M., Chen, X., Spurdle, A., Change-Claude, J., Flesch-Janys, D., Couch, F. J., Olson, J. E., Severi, G., Baglietto, L., Borresen-Dale, A. L., Kristensen, V., Hunter, D. J., Hankinson, S. E., Devilee, P., Vreeswijk, M., Lissowska, J., Brinton, L., Liu, J., Hall, P., Kang, D., Yoo, K. Y., Shen, C. Y., Yu, J. C., Anton-Culver, H., Ziogoas, A., Sigurdson, A., Struewing, J., Easton, D. F., Garcia-Closas, M., Humphreys, M. K., Morrison, J., Pharoah, P. D., Pooley, K. A., and Chenevix-Trench, G. Association of Esr1 Gene Tagging Snps with Breast Cancer Risk. Hum Mol Genet, 18 (2009), 1131-9. [Pubmed Link]
  75. Chand, A. L., Simpson, E. R., and Clyne, C. D. Aromatase Expression Is Increased in Brca1 Mutation Carriers. BMC Cancer, 9 (2009), 148. [Pubmed Link]
  76. Ahmed, S., Thomas, G., Ghoussaini, M., Healey, C. S., Humphreys, M. K., Platte, R., Morrison, J., Maranian, M., Pooley, K. A., Luben, R., Eccles, D., Evans, D. G., Fletcher, O., Johnson, N., dos Santos Silva, I., Peto, J., Stratton, M. R., Rahman, N., Jacobs, K., Prentice, R., Anderson, G. L., Rajkovic, A., Curb, J. D., Ziegler, R. G., Berg, C. D., Buys, S. S., McCarty, C. A., Feigelson, H. S., Calle, E. E., Thun, M. J., Diver, W. R., Bojesen, S., Nordestgaard, B. G., Flyger, H., Dork, T., Schurmann, P., Hillemanns, P., Karstens, J. H., Bogdanova, N. V., Antonenkova, N. N., Zalutsky, I. V., Bermisheva, M., Fedorova, S., Khusnutdinova, E., Kang, D., Yoo, K. Y., Noh, D. Y., Ahn, S. H., Devilee, P., van Asperen, C. J., Tollenaar, R. A., Seynaeve, C., Garcia-Closas, M., Lissowska, J., Brinton, L., Peplonska, B., Nevanlinna, H., Heikkinen, T., Aittomaki, K., Blomqvist, C., Hopper, J. L., Southey, M. C., Smith, L., Spurdle, A. B., Schmidt, M. K., Broeks, A., van Hien, R. R., Cornelissen, S., Milne, R. L., Ribas, G., Gonzalez-Neira, A., Benitez, J., Schmutzler, R. K., Burwinkel, B., Bartram, C. R., Meindl, A., Brauch, H., Justenhoven, C., Hamann, U., Chang-Claude, J., Hein, R., Wang-Gohrke, S., Lindblom, A., Margolin, S., Mannermaa, A., Kosma, V. M., Kataja, V., Olson, J. E., Wang, X., Fredericksen, Z., Giles, G. G., Severi, G., Baglietto, L., English, D. R., Hankinson, S. E., Cox, D. G., Kraft, P., Vatten, L. J., Hveem, K., Kumle, M., Sigurdson, A., Doody, M., Bhatti, P., Alexander, B. H., Hooning, M. J., van den Ouweland, A. M., Oldenburg, R. A., Schutte, M., Hall, P., Czene, K., Liu, J., Li, Y., Cox, A., Elliott, G., Brock, I., Reed, M. W., Shen, C. Y., Yu, J. C., Hsu, G. C., Chen, S. T., Anton-Culver, H., Ziogas, A., Andrulis, I. L., Knight, J. A., Beesley, J., Goode, E. L., Couch, F., Chenevix-Trench, G., Hoover, R. N., Ponder, B. A., Hunter, D. J., Pharoah, P. D., Dunning, A. M., Chanock, S. J., and Easton, D. F. Newly Discovered Breast Cancer Susceptibility Loci on 3p24 and 17q23.2. Nat Genet, 41 (2009), 585-90. [Pubmed Link]
  77. Gaudet, M. M., Milne, R. L., Cox, A., Camp, N. J., Goode, E. L., Humphreys, M. K., Dunning, A. M., Morrison, J., Giles, G. G., Severi, G., Baglietto, L., English, D. R., Couch, F. J., Olson, J. E., Wang, X., Chang-Claude, J., Flesch-Janys, D., Abbas, S., Salazar, R., Mannermaa, A., Kataja, V., Kosma, V. M., Lindblom, A., Margolin, S., Heikkinen, T., Kampjarvi, K., Aaltonen, K., Nevanlinna, H., Bogdanova, N., Coinac, I., Schurmann, P., Dork, T., Bartram, C. R., Schmutzler, R. K., Tchatchou, S., Burwinkel, B., Brauch, H., Torres, D., Hamann, U., Justenhoven, C., Ribas, G., Arias, J. I., Benitez, J., Bojesen, S. E., Nordestgaard, B. G., Flyger, H. L., Peto, J., Fletcher, O., Johnson, N., Dos Santos Silva, I., Fasching, P. A., Beckmann, M. W., Strick, R., Ekici, A. B., Broeks, A., Schmidt, M. K., van Leeuwen, F. E., Van't Veer, L. J., Southey, M. C., Hopper, J. L., Apicella, C., Haiman, C. A., Henderson, B. E., Le Marchand, L., Kolonel, L. N., Kristensen, V., Grenaker Alnaes, G., Hunter, D. J., Kraft, P., Cox, D. G., Hankinson, S. E., Seynaeve, C., Vreeswijk, M. P., Tollenaar, R. A., Devilee, P., Chanock, S., Lissowska, J., Brinton, L., Peplonska, B., Czene, K., Hall, P., Li, Y., Liu, J., Balasubramanian, S., Rafii, S., Reed, M. W., Pooley, K. A., Conroy, D., Baynes, C., Kang, D., Yoo, K. Y., Noh, D. Y., Ahn, S. H., Shen, C. Y., Wang, H. C., Yu, J. C., Wu, P. E., Anton-Culver, H., Ziogoas, A., Egan, K., Newcomb, P., Titus-Ernstoff, L., Trentham Dietz, A., Sigurdson, A. J., Alexander, B. H., Bhatti, P., Allen-Brady, K., Cannon-Albright, L. A., Wong, J., Chenevix-Trench, G., Spurdle, A. B., Beesley, J., Pharoah, P. D., Easton, D. F., and Garcia-Closas, M. Five Polymorphisms and Breast Cancer Risk: Results from the Breast Cancer Association Consortium. Cancer Epidemiol Biomarkers Prev, 18 (2009), 1610-6. [Pubmed Link]
  78. Milne, R. L., Benitez, J., Nevanlinna, H., Heikkinen, T., Aittomaki, K., Blomqvist, C., Arias, J. I., Zamora, M. P., Burwinkel, B., Bartram, C. R., Meindl, A., Schmutzler, R. K., Cox, A., Brock, I., Elliott, G., Reed, M. W., Southey, M. C., Smith, L., Spurdle, A. B., Hopper, J. L., Couch, F. J., Olson, J. E., Wang, X., Fredericksen, Z., Schurmann, P., Bremer, M., Hillemanns, P., Dork, T., Devilee, P., van Asperen, C. J., Tollenaar, R. A., Seynaeve, C., Hall, P., Czene, K., Liu, J., Li, Y., Ahmed, S., Dunning, A. M., Maranian, M., Pharoah, P. D., Chenevix-Trench, G., Beesley, J., Bogdanova, N. V., Antonenkova, N. N., Zalutsky, I. V., Anton-Culver, H., Ziogas, A., Brauch, H., Justenhoven, C., Ko, Y. D., Haas, S., Fasching, P. A., Strick, R., Ekici, A. B., Beckmann, M. W., Giles, G. G., Severi, G., Baglietto, L., English, D. R., Fletcher, O., Johnson, N., dos Santos Silva, I., Peto, J., Turnbull, C., Hines, S., Renwick, A., Rahman, N., Nordestgaard, B. G., Bojesen, S. E., Flyger, H., Kang, D., Yoo, K. Y., Noh, D. Y., Mannermaa, A., Kataja, V., Kosma, V. M., Garcia-Closas, M., Chanock, S., Lissowska, J., Brinton, L. A., Chang-Claude, J., Wang-Gohrke, S., Shen, C. Y., Wang, H. C., Yu, J. C., Chen, S. T., Bermisheva, M., Nikolaeva, T., Khusnutdinova, E., Humphreys, M. K., Morrison, J., Platte, R., and Easton, D. F. Risk of Estrogen Receptor-Positive and -Negative Breast Cancer and Single-Nucleotide Polymorphism 2q35-Rs13387042. J Natl Cancer Inst, 101 (2009), 1012-8. [Pubmed Link]
  79. Rebbeck, T. R., Mitra, N., Domchek, S. M., Wan, F., Chuai, S., Friebel, T. M., Panossian, S., Spurdle, A., Chenevix-Trench, G., Singer, C. F., Pfeiler, G., Neuhausen, S. L., Lynch, H. T., Garber, J. E., Weitzel, J. N., Isaacs, C., Couch, F., Narod, S. A., Rubinstein, W. S., Tomlinson, G. E., Ganz, P. A., Olopade, O. I., Tung, N., Blum, J. L., Greenberg, R., Nathanson, K. L., and Daly, M. B. Modification of Ovarian Cancer Risk by Brca1/2-Interacting Genes in a Multicenter Cohort of Brca1/2 Mutation Carriers. Cancer Res, 69 (2009), 5801-10. [Pubmed Link]
  80. Nguyen-Dumont, T., Calvez-Kelm, F. L., Forey, N., McKay-Chopin, S., Garritano, S., Gioia-Patricola, L., De Silva, D., Weigel, R., Sangrajrang, S., Lesueur, F., and Tavtigian, S. V. Description and Validation of High-Throughput Simultaneous Genotyping and Mutation Scanning by High-Resolution Melting Curve Analysis. Hum Mutat, 30 (2009), 884-90. [Pubmed Link]
  81. Lobb, E. A., Gaff, C. L., Meiser, B., Butow, P. N., Osseiran-Moisson, R., and Hallowell, N. Attendance of Men at the Familial Cancer Clinic: What They Value from the Consultation. Genet Med, 11 (2009), 434-40. [Pubmed Link]
  82. Rayoo, M., Yan, M., Takano, E. A., Bates, G. J., Brown, P. J., Banham, A. H., and Fox, S. B. Expression of the Forkhead Box Transcription Factor Foxp1 Is Associated with Oestrogen Receptor Alpha, Oestrogen Receptor Beta and Improved Survival in Familial Breast Cancers. J Clin Pathol, 62 (2009), 896-902. [Pubmed Link]
  83. Yan, M., and Fox, S. B. Does Cyclin D1 Discriminate between Brca2 and Brcax Breast Cancers? Histopathology, 55 (2009), 625-6. [Pubmed Link]
  84. Lim, E., Vaillant, F., Wu, D., Forrest, N. C., Pal, B., Hart, A. H., Asselin-Labat, M. L., Gyorki, D. E., Ward, T., Partanen, A., Feleppa, F., Huschtscha, L. I., Thorne, H. J., Fox, S. B., Yan, M., French, J. D., Brown, M. A., Smyth, G. K., Visvader, J. E., and Lindeman, G. J. Aberrant Luminal Progenitors as the Candidate Target Population for Basal Tumor Development in Brca1 Mutation Carriers. Nat Med, 15 (2009), 907-13. [Pubmed Link]
  85. Yan, M., Rayoo, M., Takano, E. A., and Fox, S. B. Brca1 Tumours Correlate with a Hif-1alpha Phenotype and Have a Poor Prognosis through Modulation of Hydroxylase Enzyme Profile Expression. Br J Cancer, 101 (2009), 1168-74. [Pubmed Link]
  86. Tavtigian, S. V., Oefner, P. J., Babikyan, D., Hartmann, A., Healey, S., Le Calvez-Kelm, F., Lesueur, F., Byrnes, G. B., Chuang, S. C., Forey, N., Feuchtinger, C., Gioia, L., Hall, J., Hashibe, M., Herte, B., McKay-Chopin, S., Thomas, A., Vallee, M. P., Voegele, C., Webb, P. M., Whiteman, D. C., Sangrajrang, S., Hopper, J. L., Southey, M. C., Andrulis, I. L., John, E. M., and Chenevix-Trench, G. Rare, Evolutionarily Unlikely Missense Substitutions in Atm Confer Increased Risk of Breast Cancer. Am J Hum Genet, 85 (2009), 427-46. [Pubmed Link]
  87. Sinilnikova, O. M., Antoniou, A. C., Simard, J., Healey, S., Leone, M., Sinnett, D., Spurdle, A. B., Beesley, J., Chen, X., Greene, M. H., Loud, J. T., Lejbkowicz, F., Rennert, G., Dishon, S., Andrulis, I. L., Domchek, S. M., Nathanson, K. L., Manoukian, S., Radice, P., Konstantopoulou, I., Blanco, I., Laborde, A. L., Duran, M., Osorio, A., Benitez, J., Hamann, U., Hogervorst, F. B., van Os, T. A., Gille, H. J., Peock, S., Cook, M., Luccarini, C., Evans, D. G., Lalloo, F., Eeles, R., Pichert, G., Davidson, R., Cole, T., Cook, J., Paterson, J., Brewer, C., Hughes, D. J., Coupier, I., Giraud, S., Coulet, F., Colas, C., Soubrier, F., Rouleau, E., Bieche, I., Lidereau, R., Demange, L., Nogues, C., Lynch, H. T., Schmutzler, R. K., Versmold, B., Engel, C., Meindl, A., Arnold, N., Sutter, C., Deissler, H., Schaefer, D., Froster, U. G., Aittomaki, K., Nevanlinna, H., McGuffog, L., Easton, D. F., Chenevix-Trench, G., and Stoppa-Lyonnet, D. The Tp53 Arg72pro and Mdm2 309g>T Polymorphisms Are Not Associated with Breast Cancer Risk in Brca1 and Brca2 Mutation Carriers. Br J Cancer, 101 (2009), 1456-60. [Pubmed Link]
  88. Antoniou, A. C., Sinilnikova, O. M., McGuffog, L., Healey, S., Nevanlinna, H., Heikkinen, T., Simard, J., Spurdle, A. B., Beesley, J., Chen, X., Neuhausen, S. L., Ding, Y. C., Couch, F. J., Wang, X., Fredericksen, Z., Peterlongo, P., Peissel, B., Bonanni, B., Viel, A., Bernard, L., Radice, P., Szabo, C. I., Foretova, L., Zikan, M., Claes, K., Greene, M. H., Mai, P. L., Rennert, G., Lejbkowicz, F., Andrulis, I. L., Ozcelik, H., Glendon, G., Gerdes, A. M., Thomassen, M., Sunde, L., Caligo, M. A., Laitman, Y., Kontorovich, T., Cohen, S., Kaufman, B., Dagan, E., Baruch, R. G., Friedman, E., Harbst, K., Barbany-Bustinza, G., Rantala, J., Ehrencrona, H., Karlsson, P., Domchek, S. M., Nathanson, K. L., Osorio, A., Blanco, I., Lasa, A., Benitez, J., Hamann, U., Hogervorst, F. B., Rookus, M. A., Collee, J. M., Devilee, P., Ligtenberg, M. J., van der Luijt, R. B., Aalfs, C. M., Waisfisz, Q., Wijnen, J., van Roozendaal, C. E., Peock, S., Cook, M., Frost, D., Oliver, C., Platte, R., Evans, D. G., Lalloo, F., Eeles, R., Izatt, L., Davidson, R., Chu, C., Eccles, D., Cole, T., Hodgson, S., Godwin, A. K., Stoppa-Lyonnet, D., Buecher, B., Leone, M., Bressac-de Paillerets, B., Remenieras, A., Caron, O., Lenoir, G. M., Sevenet, N., Longy, M., Ferrer, S. F., Prieur, F., Goldgar, D., Miron, A., John, E. M., Buys, S. S., Daly, M. B., Hopper, J. L., Terry, M. B., Yassin, Y., Singer, C., Gschwantler-Kaulich, D., Staudigl, C., Hansen, T. O., Barkardottir, R. B., Kirchhoff, T., Pal, P., Kosarin, K., Offit, K., Piedmonte, M., Rodriguez, G. C., Wakeley, K., Boggess, J. F., Basil, J., Schwartz, P. E., Blank, S. V., Toland, A. E., Montagna, M., Casella, C., Imyanitov, E. N., Allavena, A., Schmutzler, R. K., Versmold, B., Engel, C., Meindl, A., Ditsch, N., Arnold, N., Niederacher, D., Deissler, H., Fiebig, B., Suttner, C., Schonbuchner, I., Gadzicki, D., Caldes, T., de la Hoya, M., Pooley, K. A., Easton, D. F., and Chenevix-Trench, G. Common Variants in Lsp1, 2q35 and 8q24 and Breast Cancer Risk for Brca1 and Brca2 Mutation Carriers. Hum Mol Genet, 18 (2009), 4442-56. [Pubmed Link]
  89. Osorio, A., Milne, R. L., Pita, G., Peterlongo, P., Heikkinen, T., Simard, J., Chenevix-Trench, G., Spurdle, A. B., Beesley, J., Chen, X., Healey, S., Neuhausen, S. L., Ding, Y. C., Couch, F. J., Wang, X., Lindor, N., Manoukian, S., Barile, M., Viel, A., Tizzoni, L., Szabo, C. I., Foretova, L., Zikan, M., Claes, K., Greene, M. H., Mai, P., Rennert, G., Lejbkowicz, F., Barnett-Griness, O., Andrulis, I. L., Ozcelik, H., Weerasooriya, N., Gerdes, A. M., Thomassen, M., Cruger, D. G., Caligo, M. A., Friedman, E., Kaufman, B., Laitman, Y., Cohen, S., Kontorovich, T., Gershoni-Baruch, R., Dagan, E., Jernstrom, H., Askmalm, M. S., Arver, B., Malmer, B., Domchek, S. M., Nathanson, K. L., Brunet, J., Ramon, Y. C. T., Yannoukakos, D., Hamann, U., Hogervorst, F. B., Verhoef, S., Gomez Garcia, E. B., Wijnen, J. T., van den Ouweland, A., Easton, D. F., Peock, S., Cook, M., Oliver, C. T., Frost, D., Luccarini, C., Evans, D. G., Lalloo, F., Eeles, R., Pichert, G., Cook, J., Hodgson, S., Morrison, P. J., Douglas, F., Godwin, A. K., Sinilnikova, O. M., Barjhoux, L., Stoppa-Lyonnet, D., Moncoutier, V., Giraud, S., Cassini, C., Olivier-Faivre, L., Revillion, F., Peyrat, J. P., Muller, D., Fricker, J. P., Lynch, H. T., John, E. M., Buys, S., Daly, M., Hopper, J. L., Terry, M. B., Miron, A., Yassin, Y., Goldgar, D., Singer, C. F., Gschwantler-Kaulich, D., Pfeiler, G., Spiess, A. C., Hansen, T. V., Johannsson, O. T., Kirchhoff, T., Offit, K., Kosarin, K., Piedmonte, M., Rodriguez, G. C., Wakeley, K., Boggess, J. F., Basil, J., Schwartz, P. E., Blank, S. V., Toland, A. E., Montagna, M., Casella, C., Imyanitov, E. N., Allavena, A., Schmutzler, R. K., Versmold, B., Engel, C., Meindl, A., Ditsch, N., Arnold, N., Niederacher, D., Deissler, H., Fiebig, B., Varon-Mateeva, R., Schaefer, D., Froster, U. G., Caldes, T., de la Hoya, M., McGuffog, L., Antoniou, A. C., Nevanlinna, H., Radice, P., and Benitez, J. Evaluation of a Candidate Breast Cancer Associated Snp in Ercc4 as a Risk Modifier in Brca1 and Brca2 Mutation Carriers. Results from the Consortium of Investigators of Modifiers of Brca1/Brca2 (Cimba). Br J Cancer, 101 (2009), 2048-54. [Pubmed Link]
  90. Liu, J., Desai, K. V., Li, Y., Banu, S., Lee, Y. K., Qu, D., Heikkinen, T., Aaltonen, K., Muranen, T. A., Kajiji, T. S., Bonnard, C., Aittomaki, K., von Smitten, K., Blomqvist, C., Hopper, J. L., Southey, M. C., Brauch, H., Chenevix-Trench, G., Beesley, J., Spurdle, A. B., Chen, X., Czene, K., Hall, P., Nevanlinna, H., and Liu, E. T. Germ-Line Variation at a Functional P53 Binding Site Increases Susceptibility to Breast Cancer Development. The HUGO journal, 3 (2009), 31-40. [Pubmed Link]
  91. Arnold, J. M., Choong, D. Y., Thompson, E. R., Waddell, N., Lindeman, G. J., Visvader, J. E., Campbell, I. G., and Chenevix-Trench, G. Frequent Somatic Mutations of Gata3 in Non-Brca1/Brca2 Familial Breast Tumors, but Not in Brca1-, Brca2- or Sporadic Breast Tumors. Breast Cancer Res Treat, 119 (2010), 491-6. [Pubmed Link]
  92. Kiely, B. E., Jenkins, M. A., McKinley, J. M., Friedlander, M. L., Weideman, P., Milne, R. L., McLachlan, S. A., Hopper, J. L., and Phillips, K. A. Contralateral Risk-Reducing Mastectomy in Brca1 and Brca2 Mutation Carriers and Other High-Risk Women in the Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (Kconfab). Breast Cancer Res Treat, 120 (2010), 715-23. [Pubmed Link]
  93. Flanagan, J. M., Cocciardi, S., Waddell, N., Johnstone, C. N., Marsh, A., Henderson, S., Simpson, P., da Silva, L., Khanna, K., Lakhani, S., Boshoff, C., and Chenevix-Trench, G. DNA Methylome of Familial Breast Cancer Identifies Distinct Profiles Defined by Mutation Status. Am J Hum Genet, 86 (2010), 420-33. [Pubmed Link]
  94. Waddell, N., Arnold, J., Cocciardi, S., da Silva, L., Marsh, A., Riley, J., Johnstone, C. N., Orloff, M., Assie, G., Eng, C., Reid, L., Keith, P., Yan, M., Fox, S., Devilee, P., Godwin, A. K., Hogervorst, F. B., Couch, F., Grimmond, S., Flanagan, J. M., Khanna, K., Simpson, P. T., Lakhani, S. R., and Chenevix-Trench, G. Subtypes of Familial Breast Tumours Revealed by Expression and Copy Number Profiling. Breast Cancer Res Treat, 123 (2010), 661-77. [Pubmed Link]
  95. Spurdle, A. B., Fahey, P., Chen, X., McGuffog, L., Easton, D., Peock, S., Cook, M., Simard, J., Rebbeck, T. R., Antoniou, A. C., and Chenevix-Trench, G. Pooled Analysis Indicates That the Gstt1 Deletion, Gstm1 Deletion, and Gstp1 Ile105val Polymorphisms Do Not Modify Breast Cancer Risk in Brca1 and Brca2 Mutation Carriers. Breast Cancer Res Treat, 122 (2010), 281-5. [Pubmed Link]
  96. Moorman, P. G., Iversen, E. S., Marcom, P. K., Marks, J. R., Wang, F., Lee, E., Ursin, G., Rebbeck, T. R., Domchek, S. M., Arun, B., Susswein, L., Isaacs, C., Garber, J. E., Visvanathan, K., Griffin, C. A., Sutphen, R., Brzosowicz, J., Gruber, S., Finkelstein, D. M., and Schildkraut, J. M. Evaluation of Established Breast Cancer Risk Factors as Modifiers of Brca1 or Brca2: A Multi-Center Case-Only Analysis. Breast Cancer Res Treat, 124 (2010), 441-51. [Pubmed Link]
  97. Spurdle, A. B., Lakhani, S. R., Da Silva, L. M., Balleine, R. L., and Goldgar, D. E. Bayes Analysis Provides Evidence of Pathogenicity for the Brca1 C.135-1g>T (Ivs3-1) and Brca2 C.7977-1g>C (Ivs17-1) Variants Displaying in Vitro Splicing Results of Equivocal Clinical Significance. Hum Mutat, 31 (2010), E1141-5. [Pubmed Link]
  98. Walker, L. C., Thompson, B. A., Waddell, N., Grimmond, S. M., and Spurdle, A. B. Use of DNA-Damaging Agents and Rna Pooling to Assess Expression Profiles Associated with Brca1 and Brca2 Mutation Status in Familial Breast Cancer Patients. PLoS Genet, 6 (2010), e1000850. [Pubmed Link]
  99. Azzato, E. M., Tyrer, J., Fasching, P. A., Beckmann, M. W., Ekici, A. B., Schulz-Wendtland, R., Bojesen, S. E., Nordestgaard, B. G., Flyger, H., Milne, R. L., Arias, J. I., Menendez, P., Benitez, J., Chang-Claude, J., Hein, R., Wang-Gohrke, S., Nevanlinna, H., Heikkinen, T., Aittomaki, K., Blomqvist, C., Margolin, S., Mannermaa, A., Kosma, V. M., Kataja, V., Beesley, J., Chen, X., Chenevix-Trench, G., Couch, F. J., Olson, J. E., Fredericksen, Z. S., Wang, X., Giles, G. G., Severi, G., Baglietto, L., Southey, M. C., Devilee, P., Tollenaar, R. A., Seynaeve, C., Garcia-Closas, M., Lissowska, J., Sherman, M. E., Bolton, K. L., Hall, P., Czene, K., Cox, A., Brock, I. W., Elliott, G. C., Reed, M. W., Greenberg, D., Anton-Culver, H., Ziogas, A., Humphreys, M., Easton, D. F., Caporaso, N. E., and Pharoah, P. D. Association between a Germline Oca2 Polymorphism at Chromosome 15q13.1 and Estrogen Receptor-Negative Breast Cancer Survival. J Natl Cancer Inst, 102 (2010), 650-62. [Pubmed Link]
  100. Jakubowska, A., Rozkrut, D., Antoniou, A., Hamann, U., and Lubinski, J. The Leu33pro Polymorphism in the Itgb3 Gene Does Not Modify Brca1/2-Associated Breast or Ovarian Cancer Risks: Results from a Multicenter Study among 15,542 Brca1 and Brca2 Mutation Carriers. Breast Cancer Res Treat, 121 (2010), 639-49. [Pubmed Link]
  101. Verderio, P., Pizzamiglio, S., Southey, M. C., Spurdle, A. B., Hopper, J. L., Chen, X., Beesley, J., Schmutzler, R. K., Engel, C., Burwinkel, B., Bugert, P., Ficarazzi, F., Manoukian, S., Barile, M., Wappenschmidt, B., Chenevix-Trench, G., Radice, P., and Peterlongo, P. A Brca1 Promoter Variant (Rs11655505) and Breast Cancer Risk. J Med Genet, 47 (2010), 268-70. [Pubmed Link]
  102. Pierce, L. J., Phillips, K. A., Griffith, K. A., Buys, S., Gaffney, D. K., Moran, M. S., Haffty, B. G., Ben-David, M., Kaufman, B., Garber, J. E., Merajver, S. D., Balmana, J., Meirovitz, A., and Domchek, S. M. Local Therapy in Brca1 and Brca2 Mutation Carriers with Operable Breast Cancer: Comparison of Breast Conservation and Mastectomy. Breast Cancer Res Treat, 121 (2010), 389-98. [Pubmed Link]
  103. Sauty de Chalon, A., Teo, Z., Park, D. J., Odefrey, F. A., Hopper, J. L., and Southey, M. C. Are Palb2 Mutations Associated with Increased Risk of Male Breast Cancer? Breast Cancer Res Treat, 121 (2010), 253-5. [Pubmed Link]
  104. Waddell, N., Cocciardi, S., Johnson, J., Healey, S., Marsh, A., Riley, J., da Silva, L., Vargas, A. C., Reid, L., Simpson, P. T., Lakhani, S. R., and Chenevix-Trench, G. Gene Expression Profiling of Formalin-Fixed, Paraffin-Embedded Familial Breast Tumours Using the Whole Genome-Dasl Assay. J Pathol, 221 (2010), 452-61. [Pubmed Link]
  105. Wang, X., Pankratz, V. S., Fredericksen, Z., Tarrell, R., Karaus, M., McGuffog, L., Pharaoh, P. D., Ponder, B. A., Dunning, A. M., Peock, S., Cook, M., Oliver, C., Frost, D., Sinilnikova, O. M., Stoppa-Lyonnet, D., Mazoyer, S., Houdayer, C., Hogervorst, F. B., Hooning, M. J., Ligtenberg, M. J., Spurdle, A., Chenevix-Trench, G., Schmutzler, R. K., Wappenschmidt, B., Engel, C., Meindl, A., Domchek, S. M., Nathanson, K. L., Rebbeck, T. R., Singer, C. F., Gschwantler-Kaulich, D., Dressler, C., Fink, A., Szabo, C. I., Zikan, M., Foretova, L., Claes, K., Thomas, G., Hoover, R. N., Hunter, D. J., Chanock, S. J., Easton, D. F., Antoniou, A. C., and Couch, F. J. Common Variants Associated with Breast Cancer in Genome-Wide Association Studies Are Modifiers of Breast Cancer Risk in Brca1 and Brca2 Mutation Carriers. Hum Mol Genet, 19 (2010), 2886-97. [Pubmed Link]
  106. Antoniou, A. C., Wang, X., Fredericksen, Z. S., McGuffog, L., Tarrell, R., Sinilnikova, O. M., Healey, S., Morrison, J., Kartsonaki, C., Lesnick, T., Ghoussaini, M., Barrowdale, D., Peock, S., Cook, M., Oliver, C., Frost, D., Eccles, D., Evans, D. G., Eeles, R., Izatt, L., Chu, C., Douglas, F., Paterson, J., Stoppa-Lyonnet, D., Houdayer, C., Mazoyer, S., Giraud, S., Lasset, C., Remenieras, A., Caron, O., Hardouin, A., Berthet, P., Hogervorst, F. B., Rookus, M. A., Jager, A., van den Ouweland, A., Hoogerbrugge, N., van der Luijt, R. B., Meijers-Heijboer, H., Gomez Garcia, E. B., Devilee, P., Vreeswijk, M. P., Lubinski, J., Jakubowska, A., Gronwald, J., Huzarski, T., Byrski, T., Gorski, B., Cybulski, C., Spurdle, A. B., Holland, H., Goldgar, D. E., John, E. M., Hopper, J. L., Southey, M., Buys, S. S., Daly, M. B., Terry, M. B., Schmutzler, R. K., Wappenschmidt, B., Engel, C., Meindl, A., Preisler-Adams, S., Arnold, N., Niederacher, D., Sutter, C., Domchek, S. M., Nathanson, K. L., Rebbeck, T., Blum, J. L., Piedmonte, M., Rodriguez, G. C., Wakeley, K., Boggess, J. F., Basil, J., Blank, S. V., Friedman, E., Kaufman, B., Laitman, Y., Milgrom, R., Andrulis, I. L., Glendon, G., Ozcelik, H., Kirchhoff, T., Vijai, J., Gaudet, M. M., Altshuler, D., Guiducci, C., Loman, N., Harbst, K., Rantala, J., Ehrencrona, H., Gerdes, A. M., Thomassen, M., Sunde, L., Peterlongo, P., Manoukian, S., Bonanni, B., Viel, A., Radice, P., Caldes, T., de la Hoya, M., Singer, C. F., Fink-Retter, A., Greene, M. H., Mai, P. L., Loud, J. T., Guidugli, L., Lindor, N. M., Hansen, T. V., Nielsen, F. C., Blanco, I., Lazaro, C., Garber, J., Ramus, S. J., Gayther, S. A., Phelan, C., Narod, S., Szabo, C. I., Benitez, J., Osorio, A., Nevanlinna, H., Heikkinen, T., Caligo, M. A., Beattie, M. S., Hamann, U., Godwin, A. K., Montagna, M., Casella, C., Neuhausen, S. L., Karlan, B. Y., Tung, N., Toland, A. E., Weitzel, J., Olopade, O., Simard, J., Soucy, P., Rubinstein, W. S., Arason, A., Rennert, G., Martin, N. G., Montgomery, G. W., Chang-Claude, J., Flesch-Janys, D., Brauch, H., Severi, G., Baglietto, L., Cox, A., Cross, S. S., Miron, P., Gerty, S. M., Tapper, W., Yannoukakos, D., Fountzilas, G., Fasching, P. A., Beckmann, M. W., Dos Santos Silva, I., Peto, J., Lambrechts, D., Paridaens, R., Rudiger, T., Forsti, A., Winqvist, R., Pylkas, K., Diasio, R. B., Lee, A. M., Eckel-Passow, J., Vachon, C., Blows, F., Driver, K., Dunning, A., Pharoah, P. P., Offit, K., Pankratz, V. S., Hakonarson, H., Chenevix-Trench, G., Easton, D. F., and Couch, F. J. A Locus on 19p13 Modifies Risk of Breast Cancer in Brca1 Mutation Carriers and Is Associated with Hormone Receptor-Negative Breast Cancer in the General Population. Nat Genet, 42 (2010), 885-92. [Pubmed Link]
  107. Fletcher, O., Johnson, N., dos Santos Silva, I., Orr, N., Ashworth, A., Nevanlinna, H., Heikkinen, T., Aittomaki, K., Blomqvist, C., Burwinkel, B., Bartram, C. R., Meindl, A., Schmutzler, R. K., Cox, A., Brock, I., Elliott, G., Reed, M. W., Southey, M. C., Smith, L., Spurdle, A. B., Hopper, J. L., Couch, F. J., Olson, J. E., Wang, X., Fredericksen, Z., Schurmann, P., Waltes, R., Bremer, M., Dork, T., Devilee, P., van Asperen, C. J., Tollenaar, R. A., Seynaeve, C., Hall, P., Czene, K., Humphreys, K., Liu, J., Ahmed, S., Dunning, A. M., Maranian, M., Pharoah, P. D., Chenevix-Trench, G., Beesley, J., Bogdanova, N. V., Antonenkova, N. N., Zalutsky, I. V., Anton-Culver, H., Ziogas, A., Brauch, H., Ko, Y. D., Hamann, U., Fasching, P. A., Strick, R., Ekici, A. B., Beckmann, M. W., Giles, G. G., Severi, G., Baglietto, L., English, D. R., Milne, R. L., Benitez, J., Arias, J. I., Pita, G., Nordestgaard, B. G., Bojesen, S. E., Flyger, H., Kang, D., Yoo, K. Y., Noh, D. Y., Mannermaa, A., Kataja, V., Kosma, V. M., Garcia-Closas, M., Chanock, S., Lissowska, J., Brinton, L. A., Chang-Claude, J., Wang-Gohrke, S., Broeks, A., Schmidt, M. K., van Leeuwen, F. E., Van't Veer, L. J., Margolin, S., Lindblom, A., Humphreys, M. K., Morrison, J., Platte, R., Easton, D. F., and Peto, J. Missense Variants in Atm in 26,101 Breast Cancer Cases and 29,842 Controls. Cancer Epidemiol Biomarkers Prev, 19 (2010), 2143-51. [Pubmed Link]
  108. Engel, C., Versmold, B., Wappenschmidt, B., Simard, J., Easton, D. F., Peock, S., Cook, M., Oliver, C., Frost, D., Mayes, R., Evans, D. G., Eeles, R., Paterson, J., Brewer, C., McGuffog, L., Antoniou, A. C., Stoppa-Lyonnet, D., Sinilnikova, O. M., Barjhoux, L., Frenay, M., Michel, C., Leroux, D., Dreyfus, H., Toulas, C., Gladieff, L., Uhrhammer, N., Bignon, Y. J., Meindl, A., Arnold, N., Varon-Mateeva, R., Niederacher, D., Preisler-Adams, S., Kast, K., Deissler, H., Sutter, C., Gadzicki, D., Chenevix-Trench, G., Spurdle, A. B., Chen, X., Beesley, J., Olsson, H., Kristoffersson, U., Ehrencrona, H., Liljegren, A., van der Luijt, R. B., van Os, T. A., van Leeuwen, F. E., Domchek, S. M., Rebbeck, T. R., Nathanson, K. L., Osorio, A., Ramon y Cajal, T., Konstantopoulou, I., Benitez, J., Friedman, E., Kaufman, B., Laitman, Y., Mai, P. L., Greene, M. H., Nevanlinna, H., Aittomaki, K., Szabo, C. I., Caldes, T., Couch, F. J., Andrulis, I. L., Godwin, A. K., Hamann, U., and Schmutzler, R. K. Association of the Variants Casp8 D302h and Casp10 V410i with Breast and Ovarian Cancer Risk in Brca1 and Brca2 Mutation Carriers. Cancer Epidemiol Biomarkers Prev, 19 (2010), 2859-68. [Pubmed Link]
  109. Gaudet, M. M., Kirchhoff, T., Green, T., Vijai, J., Korn, J. M., Guiducci, C., Segre, A. V., McGee, K., McGuffog, L., Kartsonaki, C., Morrison, J., Healey, S., Sinilnikova, O. M., Stoppa-Lyonnet, D., Mazoyer, S., Gauthier-Villars, M., Sobol, H., Longy, M., Frenay, M., Collaborators, G. S., Hogervorst, F. B., Rookus, M. A., Collee, J. M., Hoogerbrugge, N., van Roozendaal, K. E., Piedmonte, M., Rubinstein, W., Nerenstone, S., Van Le, L., Blank, S. V., Caldes, T., de la Hoya, M., Nevanlinna, H., Aittomaki, K., Lazaro, C., Blanco, I., Arason, A., Johannsson, O. T., Barkardottir, R. B., Devilee, P., Olopade, O. I., Neuhausen, S. L., Wang, X., Fredericksen, Z. S., Peterlongo, P., Manoukian, S., Barile, M., Viel, A., Radice, P., Phelan, C. M., Narod, S., Rennert, G., Lejbkowicz, F., Flugelman, A., Andrulis, I. L., Glendon, G., Ozcelik, H., Toland, A. E., Montagna, M., D'Andrea, E., Friedman, E., Laitman, Y., Borg, A., Beattie, M., Ramus, S. J., Domchek, S. M., Nathanson, K. L., Rebbeck, T., Spurdle, A. B., Chen, X., Holland, H., John, E. M., Hopper, J. L., Buys, S. S., Daly, M. B., Southey, M. C., Terry, M. B., Tung, N., Overeem Hansen, T. V., Nielsen, F. C., Greene, M. H., Mai, P. L., Osorio, A., Duran, M., Andres, R., Benitez, J., Weitzel, J. N., Garber, J., Hamann, U., Embrace, Peock, S., Cook, M., Oliver, C., Frost, D., Platte, R., Evans, D. G., Lalloo, F., Eeles, R., Izatt, L., Walker, L., Eason, J., Barwell, J., Godwin, A. K., Schmutzler, R. K., Wappenschmidt, B., Engert, S., Arnold, N., Gadzicki, D., Dean, M., Gold, B., Klein, R. J., Couch, F. J., Chenevix-Trench, G., Easton, D. F., Daly, M. J., Antoniou, A. C., Altshuler, D. M., Offit, K., Sinilnikova, O., Barjhoux, L., Giraud, S., Leone, M., Houdayer, C., Moncoutier, V., Belotti, M., de Pauw, A., Bressac-de-Paillerets, B., Remenieras, A., Byrde, V., Caron, O., Lenoir, G., Bignon, Y. J., Uhrhammer, N., Lasset, C., Bonadona, V., Hardouin, A., Berthet, P., Bourdon, V., Noguchi, T., Eisinger, F., Coulet, F., Colas, C., Soubrier, F., Coupier, I., Peyrat, J. P., Fournier, J., Revillion, F., Vennin, P., Adenis, C., Rouleau, E., Lidereau, R., Demange, L., Nogues, C., Muller, D., Fricker, J. P., Sevenet, N., Toulas, C., Guimbaud, R., Gladieff, L., Feillel, V., Leroux, D., Dreyfus, H., Rebischung, C., Cassini, C., Faivre, L., Prieur, F., Ferrer, S. F., Venat-Bouvet, L., Lynch, H. T., Verhoef, S., Verheus, M., van 't Veer, L. J., van Leeuwen, F. E., Collee, M., van den Ouweland, A. M., Jager, A., Hooning, M. J., Tilanus-Linthorst, M. M., Seynaeve, C., van Asperen, C. J., Wijnen, J. T., Vreeswijk, M. P., Tollenaar, R. A., Ligtenberg, M. J., Ausems, M. G., van der Luijt, R. B., Aalfs, C. M., van Os, T. A., Gille, J. J., Waisfisz, Q., Meijers-Heijboer, H., Gomez-Garcia, E. B., van Roozendaal, C. E., Blok, M. J., Oosterwijk, J. C., van der Hout, A. H., Mourits, M. J., and Vasen, H. F. Common Genetic Variants and Modification of Penetrance of Brca2-Associated Breast Cancer. PLoS Genet, 6 (2010), e1001183. [Pubmed Link]
  110. Balleine, R. L., Provan, P. J., Pupo, G. M., Pathmanathan, N., Cummings, M., Farshid, G., Salisbury, E. L., Bilous, A. M., Byth, K., and Mann, G. J. Familial Concordance of Breast Cancer Pathology as an Indicator of Genotype in Multiple-Case Families. Genes Chromosomes Cancer, 49 (2010), 1082-94. [Pubmed Link]
  111. Whiley, P. J., Pettigrew, C. A., Brewster, B. L., Walker, L. C., Spurdle, A. B., and Brown, M. A. Effect of Brca2 Sequence Variants Predicted to Disrupt Exonic Splice Enhancers on Brca2 Transcripts. BMC Med Genet, 11 (2010), 80. [Pubmed Link]
  112. Price, M. A., Butow, P. N., Charles, M., Bullen, T., Meiser, B., McKinley, J. M., McLachlan, S. A., and Phillips, K. A. Predictors of Breast Cancer Screening Behavior in Women with a Strong Family History of the Disease. Breast Cancer Res Treat, 124 (2010), 509-19. [Pubmed Link]
  113. Milne, R. L., Gaudet, M. M., Spurdle, A. B., Fasching, P. A., Couch, F. J., Benitez, J., Arias Perez, J. I., Zamora, M. P., Malats, N., Dos Santos Silva, I., Gibson, L. J., Fletcher, O., Johnson, N., Anton-Culver, H., Ziogas, A., Figueroa, J., Brinton, L., Sherman, M. E., Lissowska, J., Hopper, J. L., Dite, G. S., Apicella, C., Southey, M. C., Sigurdson, A. J., Linet, M. S., Schonfeld, S. J., Freedman, D. M., Mannermaa, A., Kosma, V. M., Kataja, V., Auvinen, P., Andrulis, I. L., Glendon, G., Knight, J. A., Weerasooriya, N., Cox, A., Reed, M. W., Cross, S. S., Dunning, A. M., Ahmed, S., Shah, M., Brauch, H., Ko, Y. D., Bruning, T., Lambrechts, D., Reumers, J., Smeets, A., Wang-Gohrke, S., Hall, P., Czene, K., Liu, J., Irwanto, A. K., Chenevix-Trench, G., Holland, H., Giles, G. G., Baglietto, L., Severi, G., Bojensen, S. E., Nordestgaard, B. G., Flyger, H., John, E. M., West, D. W., Whittemore, A. S., Vachon, C., Olson, J. E., Fredericksen, Z., Kosel, M., Hein, R., Vrieling, A., Flesch-Janys, D., Heinz, J., Beckmann, M. W., Heusinger, K., Ekici, A. B., Haeberle, L., Humphreys, M. K., Morrison, J., Easton, D. F., Pharoah, P. D., Garcia-Closas, M., Goode, E. L., and Chang-Claude, J. Assessing Interactions between the Associations of Common Genetic Susceptibility Variants, Reproductive History and Body Mass Index with Breast Cancer Risk in the Breast Cancer Association Consortium: A Combined Case-Control Study. Breast Cancer Res, 12 (2010), R110. [Pubmed Link]
  114. Walker, L. C., Fredericksen, Z. S., Wang, X., Tarrell, R., Pankratz, V. S., Lindor, N. M., Beesley, J., Healey, S., Chen, X., Stoppa-Lyonnet, D., Tirapo, C., Giraud, S., Mazoyer, S., Muller, D., Fricker, J. P., Delnatte, C., Schmutzler, R. K., Wappenschmidt, B., Engel, C., Schonbuchner, I., Deissler, H., Meindl, A., Hogervorst, F. B., Verheus, M., Hooning, M. J., van den Ouweland, A. M., Nelen, M. R., Ausems, M. G., Aalfs, C. M., van Asperen, C. J., Devilee, P., Gerrits, M. M., Waisfisz, Q., Szabo, C. I., Easton, D. F., Peock, S., Cook, M., Oliver, C. T., Frost, D., Harrington, P., Evans, D. G., Lalloo, F., Eeles, R., Izatt, L., Chu, C., Davidson, R., Eccles, D., Ong, K. R., Cook, J., Rebbeck, T., Nathanson, K. L., Domchek, S. M., Singer, C. F., Gschwantler-Kaulich, D., Dressler, A. C., Pfeiler, G., Godwin, A. K., Heikkinen, T., Nevanlinna, H., Agnarsson, B. A., Caligo, M. A., Olsson, H., Kristoffersson, U., Liljegren, A., Arver, B., Karlsson, P., Melin, B., Sinilnikova, O. M., McGuffog, L., Antoniou, A. C., Chenevix-Trench, G., Spurdle, A. B., and Couch, F. J. Evidence for Smad3 as a Modifier of Breast Cancer Risk in Brca2 Mutation Carriers. Breast Cancer Res, 12 (2010), R102. [Pubmed Link]
  115. Walker, L. C., Whiley, P. J., Couch, F. J., Farrugia, D. J., Healey, S., Eccles, D. M., Lin, F., Butler, S. A., Goff, S. A., Thompson, B. A., Lakhani, S. R., Da Silva, L. M., Tavtigian, S. V., Goldgar, D. E., Brown, M. A., and Spurdle, A. B. Detection of Splicing Aberrations Caused by Brca1 and Brca2 Sequence Variants Encoding Missense Substitutions: Implications for Prediction of Pathogenicity. Hum Mutat, 31 (2010), E1484-505. [Pubmed Link]
  116. Southey, M. C., Teo, Z. L., Dowty, J. G., Odefrey, F. A., Park, D. J., Tischkowitz, M., Sabbaghian, N., Apicella, C., Byrnes, G. B., Winship, I., Baglietto, L., Giles, G. G., Goldgar, D. E., Foulkes, W. D., and Hopper, J. L. A Palb2 Mutation Associated with High Risk of Breast Cancer. Breast Cancer Res, 12 (2010), R109. [Pubmed Link]
  117. Whitaker, H. C., Kote-Jarai, Z., Ross-Adams, H., Warren, A. Y., Burge, J., George, A., Bancroft, E., Jhavar, S., Leongamornlert, D., Tymrakiewicz, M., Saunders, E., Page, E., Mitra, A., Mitchell, G., Lindeman, G. J., Evans, D. G., Blanco, I., Mercer, C., Rubinstein, W. S., Clowes, V., Douglas, F., Hodgson, S., Walker, L., Donaldson, A., Izatt, L., Dorkins, H., Male, A., Tucker, K., Stapleton, A., Lam, J., Kirk, J., Lilja, H., Easton, D., Cooper, C., Eeles, R., and Neal, D. E. The Rs10993994 Risk Allele for Prostate Cancer Results in Clinically Relevant Changes in Microseminoprotein-Beta Expression in Tissue and Urine. PloS one, 5 (2010), e13363. [Pubmed Link]
  118. Mitra, A. V., Jameson, C., Barbachano, Y., Sodha, N., Kote-Jarai, Z., Javed, A., Bancroft, E., Fletcher, A., Cooper, C., Peock, S., Easton, D., Eeles, R., and Foster, C. S. Elevated Expression of Ki-67 Identifies Aggressive Prostate Cancers but Does Not Distinguish Brca1 or Brca2 Mutation Carriers. Oncology reports, 23 (2010), 299-305. [Pubmed Link]
  119. Antoniou, A. C., Beesley, J., McGuffog, L., Sinilnikova, O. M., Healey, S., Neuhausen, S. L., Ding, Y. C., Rebbeck, T. R., Weitzel, J. N., Lynch, H. T., Isaacs, C., Ganz, P. A., Tomlinson, G., Olopade, O. I., Couch, F. J., Wang, X., Lindor, N. M., Pankratz, V. S., Radice, P., Manoukian, S., Peissel, B., Zaffaroni, D., Barile, M., Viel, A., Allavena, A., Dall'Olio, V., Peterlongo, P., Szabo, C. I., Zikan, M., Claes, K., Poppe, B., Foretova, L., Mai, P. L., Greene, M. H., Rennert, G., Lejbkowicz, F., Glendon, G., Ozcelik, H., Andrulis, I. L., Thomassen, M., Gerdes, A. M., Sunde, L., Cruger, D., Birk Jensen, U., Caligo, M., Friedman, E., Kaufman, B., Laitman, Y., Milgrom, R., Dubrovsky, M., Cohen, S., Borg, A., Jernstrom, H., Lindblom, A., Rantala, J., Stenmark-Askmalm, M., Melin, B., Nathanson, K., Domchek, S., Jakubowska, A., Lubinski, J., Huzarski, T., Osorio, A., Lasa, A., Duran, M., Tejada, M. I., Godino, J., Benitez, J., Hamann, U., Kriege, M., Hoogerbrugge, N., van der Luijt, R. B., van Asperen, C. J., Devilee, P., Meijers-Heijboer, E. J., Blok, M. J., Aalfs, C. M., Hogervorst, F., Rookus, M., Cook, M., Oliver, C., Frost, D., Conroy, D., Evans, D. G., Lalloo, F., Pichert, G., Davidson, R., Cole, T., Cook, J., Paterson, J., Hodgson, S., Morrison, P. J., Porteous, M. E., Walker, L., Kennedy, M. J., Dorkins, H., Peock, S., Godwin, A. K., Stoppa-Lyonnet, D., de Pauw, A., Mazoyer, S., Bonadona, V., Lasset, C., Dreyfus, H., Leroux, D., Hardouin, A., Berthet, P., Faivre, L., Loustalot, C., Noguchi, T., Sobol, H., Rouleau, E., Nogues, C., Frenay, M., Venat-Bouvet, L., Hopper, J. L., Daly, M. B., Terry, M. B., John, E. M., Buys, S. S., Yassin, Y., Miron, A., Goldgar, D., Singer, C. F., Dressler, A. C., Gschwantler-Kaulich, D., Pfeiler, G., Hansen, T. V., Jonson, L., Agnarsson, B. A., Kirchhoff, T., Offit, K., Devlin, V., Dutra-Clarke, A., Piedmonte, M., Rodriguez, G. C., Wakeley, K., Boggess, J. F., Basil, J., Schwartz, P. E., Blank, S. V., Toland, A. E., Montagna, M., Casella, C., Imyanitov, E., Tihomirova, L., Blanco, I., Lazaro, C., Ramus, S. J., Sucheston, L., Karlan, B. Y., Gross, J., Schmutzler, R., Wappenschmidt, B., Engel, C., Meindl, A., Lochmann, M., Arnold, N., Heidemann, S., Varon-Mateeva, R., Niederacher, D., Sutter, C., Deissler, H., Gadzicki, D., Preisler-Adams, S., Kast, K., Schonbuchner, I., Caldes, T., de la Hoya, M., Aittomaki, K., Nevanlinna, H., Simard, J., Spurdle, A. B., Holland, H., Chen, X., Platte, R., Chenevix-Trench, G., and Easton, D. F. Common Breast Cancer Susceptibility Alleles and the Risk of Breast Cancer for Brca1 and Brca2 Mutation Carriers: Implications for Risk Prediction. Cancer Res, 70 (2010), 9742-54. [Pubmed Link]
  120. Yan, M., Rayoo, M., Takano, E. A., and Fox, S. B. Nuclear and Cytoplasmic Expressions of Erbeta1 and Erbeta2 Are Predictive of Response to Therapy and Alters Prognosis in Familial Breast Cancers. Breast Cancer Res Treat, 126 (2011), 395-405. [Pubmed Link]
  121. Ramus, S. J., Kartsonaki, C., Gayther, S. A., Pharoah, P. D., Sinilnikova, O. M., Beesley, J., Chen, X., McGuffog, L., Healey, S., Couch, F. J., Wang, X., Fredericksen, Z., Peterlongo, P., Manoukian, S., Peissel, B., Zaffaroni, D., Roversi, G., Barile, M., Viel, A., Allavena, A., Ottini, L., Papi, L., Gismondi, V., Capra, F., Radice, P., Greene, M. H., Mai, P. L., Andrulis, I. L., Glendon, G., Ozcelik, H., Thomassen, M., Gerdes, A. M., Kruse, T. A., Cruger, D., Jensen, U. B., Caligo, M. A., Olsson, H., Kristoffersson, U., Lindblom, A., Arver, B., Karlsson, P., Stenmark Askmalm, M., Borg, A., Neuhausen, S. L., Ding, Y. C., Nathanson, K. L., Domchek, S. M., Jakubowska, A., Lubinski, J., Huzarski, T., Byrski, T., Gronwald, J., Gorski, B., Cybulski, C., Debniak, T., Osorio, A., Duran, M., Tejada, M. I., Benitez, J., Hamann, U., Rookus, M. A., Verhoef, S., Tilanus-Linthorst, M. A., Vreeswijk, M. P., Bodmer, D., Ausems, M. G., van Os, T. A., Asperen, C. J., Blok, M. J., Meijers-Heijboer, H. E., Peock, S., Cook, M., Oliver, C., Frost, D., Dunning, A. M., Evans, D. G., Eeles, R., Pichert, G., Cole, T., Hodgson, S., Brewer, C., Morrison, P. J., Porteous, M., Kennedy, M. J., Rogers, M. T., Side, L. E., Donaldson, A., Gregory, H., Godwin, A., Stoppa-Lyonnet, D., Moncoutier, V., Castera, L., Mazoyer, S., Barjhoux, L., Bonadona, V., Leroux, D., Faivre, L., Lidereau, R., Nogues, C., Bignon, Y. J., Prieur, F., Collonge-Rame, M. A., Venat-Bouvet, L., Fert-Ferrer, S., Miron, A., Buys, S. S., Hopper, J. L., Daly, M. B., John, E. M., Terry, M. B., Goldgar, D., Hansen, T. O., Jonson, L., Ejlertsen, B., Agnarsson, B. A., Offit, K., Kirchhoff, T., Vijai, J., Dutra-Clarke, A. V., Przybylo, J. A., Montagna, M., Casella, C., Imyanitov, E. N., Janavicius, R., Blanco, I., Lazaro, C., Moysich, K. B., Karlan, B. Y., Gross, J., Beattie, M. S., Schmutzler, R., Wappenschmidt, B., Meindl, A., Ruehl, I., Fiebig, B., Sutter, C., Arnold, N., Deissler, H., Varon-Mateeva, R., Kast, K., Niederacher, D., Gadzicki, D., Caldes, T., de la Hoya, M., Nevanlinna, H., Aittomaki, K., Simard, J., Soucy, P., Spurdle, A. B., Holland, H., Chenevix-Trench, G., Easton, D. F., and Antoniou, A. C. Genetic Variation at 9p22.2 and Ovarian Cancer Risk for Brca1 and Brca2 Mutation Carriers. J Natl Cancer Inst, 103 (2011), 105-16. [Pubmed Link]
  122. Kaufman, B., Laitman, Y., Ziv, E., Hamann, U., Torres, D., Lahad, E. L., Beeri, R., Renbaum, P., Jakubowska, A., Lubinski, J., Huzarski, T., Toloczko-Grabarek, A., Jaworska, K., Durda, K., Sprudle, A. B., Chenevix-Trench, G., Simard, J., Easton, D. F., Antonis, A., Szabo, C., and Friedman, E. The Cyp17a1 -34t > C Polymorphism and Breast Cancer Risk in Brca1 and Brca2 Mutation Carriers. Breast Cancer Res Treat, 126 (2011), 521-7. [Pubmed Link]
  123. Beesley, J., Johnatty, S. E., Chen, X., Spurdle, A. B., Peterlongo, P., Barile, M., Pensotti, V., Manoukian, S., Radice, P., and Chenevix-Trench, G. No Evidence for an Association between the Earwax-Associated Polymorphism in Abcc11 and Breast Cancer Risk in Caucasian Women. Breast Cancer Res Treat, 126 (2011), 235-9. [Pubmed Link]
  124. Yang, X. R., Chang-Claude, J., Goode, E. L., Couch, F. J., Nevanlinna, H., Milne, R. L., Gaudet, M., Schmidt, M. K., Broeks, A., Cox, A., Fasching, P. A., Hein, R., Spurdle, A. B., Blows, F., Driver, K., Flesch-Janys, D., Heinz, J., Sinn, P., Vrieling, A., Heikkinen, T., Aittomaki, K., Heikkila, P., Blomqvist, C., Lissowska, J., Peplonska, B., Chanock, S., Figueroa, J., Brinton, L., Hall, P., Czene, K., Humphreys, K., Darabi, H., Liu, J., Van 't Veer, L. J., van Leeuwen, F. E., Andrulis, I. L., Glendon, G., Knight, J. A., Mulligan, A. M., O'Malley, F. P., Weerasooriya, N., John, E. M., Beckmann, M. W., Hartmann, A., Weihbrecht, S. B., Wachter, D. L., Jud, S. M., Loehberg, C. R., Baglietto, L., English, D. R., Giles, G. G., McLean, C. A., Severi, G., Lambrechts, D., Vandorpe, T., Weltens, C., Paridaens, R., Smeets, A., Neven, P., Wildiers, H., Wang, X., Olson, J. E., Cafourek, V., Fredericksen, Z., Kosel, M., Vachon, C., Cramp, H. E., Connley, D., Cross, S. S., Balasubramanian, S. P., Reed, M. W., Dork, T., Bremer, M., Meyer, A., Karstens, J. H., Ay, A., Park-Simon, T. W., Hillemanns, P., Arias Perez, J. I., Menendez Rodriguez, P., Zamora, P., Benitez, J., Ko, Y. D., Fischer, H. P., Hamann, U., Pesch, B., Bruning, T., Justenhoven, C., Brauch, H., Eccles, D. M., Tapper, W. J., Gerty, S. M., Sawyer, E. J., Tomlinson, I. P., Jones, A., Kerin, M., Miller, N., McInerney, N., Anton-Culver, H., Ziogas, A., Shen, C. Y., Hsiung, C. N., Wu, P. E., Yang, S. L., Yu, J. C., Chen, S. T., Hsu, G. C., Haiman, C. A., Henderson, B. E., Le Marchand, L., Kolonel, L. N., Lindblom, A., Margolin, S., Jakubowska, A., Lubinski, J., Huzarski, T., Byrski, T., Gorski, B., Gronwald, J., Hooning, M. J., Hollestelle, A., van den Ouweland, A. M., Jager, A., Kriege, M., Tilanus-Linthorst, M. M., Collee, M., Wang-Gohrke, S., Pylkas, K., Jukkola-Vuorinen, A., Mononen, K., Grip, M., Hirvikoski, P., Winqvist, R., Mannermaa, A., Kosma, V. M., Kauppinen, J., Kataja, V., Auvinen, P., Soini, Y., Sironen, R., Bojesen, S. E., Orsted, D. D., Kaur-Knudsen, D., Flyger, H., Nordestgaard, B. G., Holland, H., Chenevix-Trench, G., Manoukian, S., Barile, M., Radice, P., Hankinson, S. E., Hunter, D. J., Tamimi, R., Sangrajrang, S., Brennan, P., McKay, J., Odefrey, F., Gaborieau, V., Devilee, P., Huijts, P. E., Tollenaar, R. A., Seynaeve, C., Dite, G. S., Apicella, C., Hopper, J. L., Hammet, F., Tsimiklis, H., Smith, L. D., Southey, M. C., Humphreys, M. K., Easton, D., Pharoah, P., Sherman, M. E., and Garcia-Closas, M. Associations of Breast Cancer Risk Factors with Tumor Subtypes: A Pooled Analysis from the Breast Cancer Association Consortium Studies. J Natl Cancer Inst, 103 (2011), 250-63. [Pubmed Link]
  125. Pharoah, P. D., Palmieri, R. T., Ramus, S. J., Gayther, S. A., Andrulis, I. L., Anton-Culver, H., Antonenkova, N., Antoniou, A. C., Goldgar, D., Beattie, M. S., Beckmann, M. W., Birrer, M. J., Bogdanova, N., Bolton, K. L., Brewster, W., Brooks-Wilson, A., Brown, R., Butzow, R., Caldes, T., Caligo, M. A., Campbell, I., Chang-Claude, J., Chen, Y. A., Cook, L. S., Couch, F. J., Cramer, D. W., Cunningham, J. M., Despierre, E., Doherty, J. A., Dork, T., Durst, M., Eccles, D. M., Ekici, A. B., Easton, D., Fasching, P. A., de Fazio, A., Fenstermacher, D. A., Flanagan, J. M., Fridley, B. L., Friedman, E., Gao, B., Sinilnikova, O., Gentry-Maharaj, A., Godwin, A. K., Goode, E. L., Goodman, M. T., Gross, J., Hansen, T. V., Harnett, P., Rookus, M., Heikkinen, T., Hein, R., Hogdall, C., Hogdall, E., Iversen, E. S., Jakubowska, A., Johnatty, S. E., Karlan, B. Y., Kauff, N. D., Kaye, S. B., Chenevix-Trench, G., Kelemen, L. E., Kiemeney, L. A., Kjaer, S. K., Lambrechts, D., Lapolla, J. P., Lazaro, C., Le, N. D., Leminen, A., Leunen, K., Levine, D. A., Lu, Y., Lundvall, L., Macgregor, S., Marees, T., Massuger, L. F., McLaughlin, J. R., Menon, U., Montagna, M., Moysich, K. B., Narod, S. A., Nathanson, K. L., Nedergaard, L., Ness, R. B., Nevanlinna, H., Nickels, S., Osorio, A., Paul, J., Pearce, C. L., Phelan, C. M., Pike, M. C., Radice, P., Rossing, M. A., Schildkraut, J. M., Sellers, T. A., Singer, C. F., Song, H., Stram, D. O., Sutphen, R., Lindblom, A., Terry, K. L., Tsai, Y. Y., van Altena, A. M., Vergote, I., Vierkant, R. A., Vitonis, A. F., Walsh, C., Wang-Gohrke, S., Wappenschmidt, B., Wu, A. H., Ziogas, A., Berchuck, A., and Risch, H. A. The Role of Kras Rs61764370 in Invasive Epithelial Ovarian Cancer: Implications for Clinical Testing. Clin Cancer Res, 17 (2011), 3742-50. [Pubmed Link]
  126. Schrader, K. A., Masciari, S., Boyd, N., Salamanca, C., Senz, J., Saunders, D. N., Yorida, E., Maines-Bandiera, S., Kaurah, P., Tung, N., Robson, M. E., Ryan, P. D., Olopade, O. I., Domchek, S. M., Ford, J., Isaacs, C., Brown, P., Balmana, J., Razzak, A. R., Miron, P., Coffey, K., Terry, M. B., John, E. M., Andrulis, I. L., Knight, J. A., O'Malley, F. P., Daly, M., Bender, P., Moore, R., Southey, M. C., Hopper, J. L., Garber, J. E., and Huntsman, D. G. Germline Mutations in Cdh1 Are Infrequent in Women with Early-Onset or Familial Lobular Breast Cancers. J Med Genet, 48 (2011), 64-8. [Pubmed Link]
  127. Ratnayake, P., Wakefield, C. E., Meiser, B., Suthers, G., Price, M. A., Duffy, J., and Tucker, K. An Exploration of the Communication Preferences Regarding Genetic Testing in Individuals from Families with Identified Breast/Ovarian Cancer Mutations. Fam Cancer, 10 (2011), 97-105. [Pubmed Link]
  128. Wakefield, C. E., Ratnayake, P., Meiser, B., Suthers, G., Price, M. A., Duffy, J., and Tucker, K. For All My Family's Sake, I Should Go and Find Out: An Australian Report on Genetic Counseling and Testing Uptake in Individuals at High Risk of Breast and/or Ovarian Cancer. Genet Test Mol Biomarkers, 15 (2011), 379-85. [Pubmed Link]
  129. Kiely, B. E., Friedlander, M. L., Milne, R. L., Stanhope, L., Russell, P., Jenkins, M. A., Weideman, P., McLachlan, S. A., Grant, P., Hopper, J. L., and Phillips, K. A. Adequacy of Risk-Reducing Gynaecologic Surgery in Brca1 or Brca2 Mutation Carriers and Other Women at High Risk of Pelvic Serous Cancer. Fam Cancer, 10 (2011), 505-14. [Pubmed Link]
  130. Duffy, D. L., Antill, Y. C., Stewart, C. J., Young, J. P., and Spurdle, A. B. Report of Endometrial Cancer in Australian Brca1 and Brca2 Mutation-Positive Families. Twin Res Hum Genet, 14 (2011), 111-8. [Pubmed Link]
  131. Whiley, P. J., Guidugli, L., Walker, L. C., Healey, S., Thompson, B. A., Lakhani, S. R., Da Silva, L. M., Tavtigian, S. V., Goldgar, D. E., Brown, M. A., Couch, F. J., and Spurdle, A. B. Splicing and Multifactorial Analysis of Intronic Brca1 and Brca2 Sequence Variants Identifies Clinically Significant Splicing Aberrations up to 12 Nucleotides from the Intron/Exon Boundary. Hum Mutat, 32 (2011), 678-87. [Pubmed Link]
  132. Martrat, G., Maxwell, C. A., Tominaga, E., Porta-de-la-Riva, M., Bonifaci, N., Gomez-Baldo, L., Bogliolo, M., Lazaro, C., Blanco, I., Brunet, J., Aguilar, H., Fernandez-Rodriguez, J., Seal, S., Renwick, A., Rahman, N., Kuhl, J., Neveling, K., Schindler, D., Ramirez, M. J., Castella, M., Hernandez, G., Easton, D. F., Peock, S., Cook, M., Oliver, C. T., Frost, D., Platte, R., Evans, D. G., Lalloo, F., Eeles, R., Izatt, L., Chu, C., Davidson, R., Ong, K. R., Cook, J., Douglas, F., Hodgson, S., Brewer, C., Morrison, P. J., Porteous, M., Peterlongo, P., Manoukian, S., Peissel, B., Zaffaroni, D., Roversi, G., Barile, M., Viel, A., Pasini, B., Ottini, L., Putignano, A. L., Savarese, A., Bernard, L., Radice, P., Healey, S., Spurdle, A., Chen, X., Beesley, J., Rookus, M. A., Verhoef, S., Tilanus-Linthorst, M. A., Vreeswijk, M. P., Asperen, C. J., Bodmer, D., Ausems, M. G., van Os, T. A., Blok, M. J., Meijers-Heijboer, H. E., Hogervorst, F. B., Goldgar, D. E., Buys, S., John, E. M., Miron, A., Southey, M., Daly, M. B., Harbst, K., Borg, A., Rantala, J., Barbany-Bustinza, G., Ehrencrona, H., Stenmark-Askmalm, M., Kaufman, B., Laitman, Y., Milgrom, R., Friedman, E., Domchek, S. M., Nathanson, K. L., Rebbeck, T. R., Johannsson, O. T., Couch, F. J., Wang, X., Fredericksen, Z., Cuadras, D., Moreno, V., Pientka, F. K., Depping, R., Caldes, T., Osorio, A., Benitez, J., Bueren, J., Heikkinen, T., Nevanlinna, H., Hamann, U., Torres, D., Caligo, M. A., Godwin, A. K., Imyanitov, E. N., Janavicius, R., Sinilnikova, O. M., Stoppa-Lyonnet, D., Mazoyer, S., Verny-Pierre, C., Castera, L., de Pauw, A., Bignon, Y. J., Uhrhammer, N., Peyrat, J. P., Vennin, P., Ferrer, S. F., Collonge-Rame, M. A., Mortemousque, I., McGuffog, L., Chenevix-Trench, G., Pereira-Smith, O. M., Antoniou, A. C., Ceron, J., Tominaga, K., Surralles, J., and Pujana, M. A. Exploring the Link between Morf4l1 and Risk of Breast Cancer. Breast Cancer Res, 13 (2011), R40. [Pubmed Link]
  133. Nguyen-Dumont, T., Jordheim, L. P., Michelon, J., Forey, N., McKay-Chopin, S., Sinilnikova, O., Le Calvez-Kelm, F., Southey, M. C., Tavtigian, S. V., and Lesueur, F. Detecting Differential Allelic Expression Using High-Resolution Melting Curve Analysis: Application to the Breast Cancer Susceptibility Gene Chek2. BMC Med Genomics, 4 (2011), 39. [Pubmed Link]
  134. Thorne, H., Willems, A. J., Niedermayr, E., Hoh, I. M., Li, J., Clouston, D., Mitchell, G., Fox, S., Hopper, J. L., and Bolton, D. Decreased Prostate Cancer-Specific Survival of Men with Brca2 Mutations from Multiple Breast Cancer Families. Cancer Prev Res (Phila), 4 (2011), 1002-10. [Pubmed Link]
  135. Milne, R. L., Goode, E. L., Garcia-Closas, M., Couch, F. J., Severi, G., Hein, R., Fredericksen, Z., Malats, N., Zamora, M. P., Perez, J. I., Benitez, J., Dork, T., Schurmann, P., Karstens, J. H., Hillemanns, P., Cox, A., Brock, I. W., Elliot, G., Cross, S. S., Seal, S., Turnbull, C., Renwick, A., Rahman, N., Shen, C. Y., Yu, J. C., Huang, C. S., Hou, M. F., Nordestgaard, B. G., Bojesen, S. E., Lanng, C., Alnaes, G. G., Kristensen, V., Borrensen-Dale, A. L., Hopper, J. L., Dite, G. S., Apicella, C., Southey, M. C., Lambrechts, D., Yesilyurt, B. T., Floris, G., Leunen, K., Sangrajrang, S., Gaborieau, V., Brennan, P., McKay, J., Chang-Claude, J., Wang-Gohrke, S., Radice, P., Peterlongo, P., Manoukian, S., Barile, M., Giles, G. G., Baglietto, L., John, E. M., Miron, A., Chanock, S. J., Lissowska, J., Sherman, M. E., Figueroa, J. D., Bogdanova, N. V., Antonenkova, N. N., Zalutsky, I. V., Rogov, Y. I., Fasching, P. A., Bayer, C. M., Ekici, A. B., Beckmann, M. W., Brenner, H., Muller, H., Arndt, V., Stegmaier, C., Andrulis, I. L., Knight, J. A., Glendon, G., Mulligan, A. M., Mannermaa, A., Kataja, V., Kosma, V. M., Hartikainen, J. M., Meindl, A., Heil, J., Bartram, C. R., Schmutzler, R. K., Thomas, G. D., Hoover, R. N., Fletcher, O., Gibson, L. J., Dos Santos Silva, I., Peto, J., Nickels, S., Flesch-Janys, D., Anton-Culver, H., Ziogas, A., Sawyer, E., Tomlinson, I., Kerin, M., Miller, N., Schmidt, M. K., Broeks, A., Van 't Veer, L. J., Tollenaar, R. A., Pharoah, P. D., Dunning, A. M., Pooley, K. A., Marme, F., Schneeweiss, A., Sohn, C., Burwinkel, B., Jakubowska, A., Lubinski, J., Jaworska, K., Durda, K., Kang, D., Yoo, K. Y., Noh, D. Y., Ahn, S. H., Hunter, D. J., Hankinson, S. E., Kraft, P., Lindstrom, S., Chen, X., Beesley, J., Hamann, U., Harth, V., Justenhoven, C., Winqvist, R., Pylkas, K., Jukkola-Vuorinen, A., Grip, M., Hooning, M., Hollestelle, A., Oldenburg, R. A., Tilanus-Linthorst, M., Khusnutdinova, E., Bermisheva, M., Prokofieva, D., Farahtdinova, A., Olson, J. E., Wang, X., Humphreys, M. K., Wang, Q., Chenevix-Trench, G., and Easton, D. F. Confirmation of 5p12 as a Susceptibility Locus for Progesterone-Receptor-Positive, Lower Grade Breast Cancer. Cancer Epidemiol Biomarkers Prev, (2011). [Pubmed Link]
  136. Milne, R. L., Lorenzo-Bermejo, J., Burwinkel, B., Malats, N., Arias, J. I., Zamora, M. P., Benitez, J., Humphreys, M. K., Garcia-Closas, M., Chanock, S. J., Lissowska, J., Sherman, M. E., Mannermaa, A., Kataja, V., Kosma, V. M., Nevanlinna, H., Heikkinen, T., Aittomaki, K., Blomqvist, C., Anton-Culver, H., Ziogas, A., Devilee, P., van Asperen, C. J., Tollenaar, R. A., Seynaeve, C., Hall, P., Czene, K., Liu, J., Irwanto, A. K., Kang, D., Yoo, K. Y., Noh, D. Y., Couch, F. J., Olson, J. E., Wang, X., Fredericksen, Z., Nordestgaard, B. G., Bojesen, S. E., Flyger, H., Margolin, S., Lindblom, A., Fasching, P. A., Schulz-Wendtland, R., Ekici, A. B., Beckmann, M. W., Wang-Gohrke, S., Shen, C. Y., Yu, J. C., Hsu, H. M., Wu, P. E., Giles, G. G., Severi, G., Baglietto, L., English, D. R., Cox, A., Brock, I., Elliott, G., Reed, M. W., Beesley, J., Chen, X., Investigators, K., Fletcher, O., Gibson, L., Dos Santos Silva, I., Peto, J., Frank, B., Heil, J., Meindl, A., Chang-Claude, J., Hein, R., Vrieling, A., Flesch-Janys, D., Southey, M. C., Smith, L., Apicella, C., Hopper, J. L., Dunning, A. M., Pooley, K. A., Pharoah, P. D., Hamann, U., Pesch, B., Ko, Y. D., Easton, D. F., and Chenevix-Trench, G. 7q21-Rs6964587 and Breast Cancer Risk: An Extended Case-Control Study by the Breast Cancer Association Consortium. J Med Genet, 48 (2011), 698-702. [Pubmed Link]
  137. Hondow, H. L., Fox, S. B., Mitchell, G., Scott, R. J., Beshay, V., Wong, S. Q., and Dobrovic, A. A High-Throughput Protocol for Mutation Scanning of the Brca1 and Brca2 Genes. BMC Cancer, 11 (2011), 265. [Pubmed Link]
  138. Harvey, S. L., Milne, R. L., McLachlan, S. A., Friedlander, M. L., Birch, K. E., Weideman, P., Goldgar, D., Hopper, J. L., and Phillips, K. A. Prospective Study of Breast Cancer Risk for Mutation Negative Women from Brca1 or Brca2 Mutation Positive Families. Breast Cancer Res Treat, (2011). [Pubmed Link]
  139. Figueroa, J. D., Garcia-Closas, M., Humphreys, M., Platte, R., Hopper, J. L., Southey, M. C., Apicella, C., Hammet, F., Schmidt, M. K., Broeks, A., Tollenaar, R. A., Van't Veer, L. J., Fasching, P. A., Beckmann, M. W., Ekici, A. B., Strick, R., Peto, J., Dos Santos Silva, I., Fletcher, O., Johnson, N., Sawyer, E., Tomlinson, I., Kerin, M., Burwinkel, B., Marme, F., Schneeweiss, A., Sohn, C., Bojesen, S., Flyger, H., Nordestgaard, B. G., Benitez, J., Milne, R. L., Ignacio Arias, J., Zamora, M. P., Brenner, H., Muller, H., Arndt, V., Rahman, N., Turnbull, C., Seal, S., Renwick, A., Brauch, H., Justenhoven, C., Bruning, T., Chang-Claude, J., Hein, R., Wang-Gohrke, S., Dork, T., Schurmann, P., Bremer, M., Hillemanns, P., Nevanlinna, H., Heikkinen, T., Aittomaki, K., Blomqvist, C., Bogdanova, N., Antonenkova, N., Rogov, Y. I., Karstens, J. H., Bermisheva, M., Prokofieva, D., Hanafievich Gantcev, S., Khusnutdinova, E., Lindblom, A., Margolin, S., Chenevix-Trench, G., Beesley, J., Chen, X., Mannermaa, A., Kosma, V. M., Soini, Y., Kataja, V., Lambrechts, D., Yesilyurt, B. T., Chrisiaens, M. R., Peeters, S., Radice, P., Peterlongo, P., Manoukian, S., Barile, M., Couch, F., Lee, A. M., Diasio, R., Wang, X., Giles, G. G., Severi, G., Baglietto, L., Maclean, C., Offit, K., Robson, M., Joseph, V., Gaudet, M., John, E. M., Winqvist, R., Pylkas, K., Jukkola-Vuorinen, A., Grip, M., Andrulis, I., Knight, J. A., Marie Mulligan, A., O'Malley, F. P., Brinton, L. A., Sherman, M. E., Lissowska, J., Chanock, S. J., Hooning, M., Martens, J. W., van den Ouweland, A. M., Collee, J. M., Hall, P., Czene, K., Cox, A., Brock, I. W., Reed, M. W., Cross, S. S., Pharoah, P., Dunning, A. M., Kang, D., Yoo, K. Y., Noh, D. Y., Ahn, S. H., Jakubowska, A., Lubinski, J., Jaworska, K., Durda, K., Sangrajrang, S., Gaborieau, V., Brennan, P., McKay, J., Shen, C. Y., Ding, S. L., Hsu, H. M., Yu, J. C., Anton-Culver, H., Ziogas, A., Ashworth, A., Swerdlow, A., Jones, M., Orr, N., Trentham-Dietz, A., Egan, K., Newcomb, P., Titus-Ernstoff, L., Easton, D., and Spurdle, A. B. Associations of Common Variants at 1p11.2 and 14q24.1 (Rad51l1) with Breast Cancer Risk and Heterogeneity by Tumor Subtype: Findings from the Breast Cancer Association Consortium. Hum Mol Genet, (2011). [Pubmed Link]
  140. Goldgar, D. E., Healey, S., Dowty, J. G., Da Silva, L., Chen, X., Spurdle, A. B., Terry, M. B., Daly, M. J., Buys, S. M., Southey, M. C., Andrulis, I., John, E. M., Khanna, K. K., Hopper, J. L., Oefner, P. J., Lakhani, S., and Chenevix-Trench, G. Rare Variants in the Atm Gene and Risk of Breast Cancer. Breast Cancer Res, 13 (2011), R73. [Pubmed Link]
  141. Antoniou, A. C., Kartsonaki, C., Sinilnikova, O. M., Soucy, P., McGuffog, L., Healey, S., Lee, A., Peterlongo, P., Manoukian, S., Peissel, B., Zaffaroni, D., Cattaneo, E., Barile, M., Pensotti, V., Pasini, B., Dolcetti, R., Giannini, G., Putignano, A. L., Varesco, L., Radice, P., Mai, P. L., Greene, M. H., Andrulis, I. L., Glendon, G., Ozcelik, H., Thomassen, M., Gerdes, A. M., Kruse, T. A., Birk Jensen, U., Cruger, D. G., Caligo, M. A., Laitman, Y., Milgrom, R., Kaufman, B., Paluch-Shimon, S., Friedman, E., Loman, N., Harbst, K., Lindblom, A., Arver, B., Ehrencrona, H., Melin, B., Nathanson, K. L., Domchek, S. M., Rebbeck, T., Jakubowska, A., Lubinski, J., Gronwald, J., Huzarski, T., Byrski, T., Cybulski, C., Gorski, B., Osorio, A., Ramon y Cajal, T., Fostira, F., Andres, R., Benitez, J., Hamann, U., Hogervorst, F. B., Rookus, M. A., Hooning, M. J., Nelen, M. R., van der Luijt, R. B., van Os, T. A., van Asperen, C. J., Devilee, P., Meijers-Heijboer, H. E., Garcia, E. B., Peock, S., Cook, M., Frost, D., Platte, R., Leyland, J., Evans, D. G., Lalloo, F., Eeles, R., Izatt, L., Adlard, J., Davidson, R., Eccles, D., Ong, K. R., Cook, J., Douglas, F., Paterson, J., Kennedy, M. J., Miedzybrodzka, Z., Godwin, A., Stoppa-Lyonnet, D., Buecher, B., Belotti, M., Tirapo, C., Mazoyer, S., Barjhoux, L., Lasset, C., Leroux, D., Faivre, L., Bronner, M., Prieur, F., Nogues, C., Rouleau, E., Pujol, P., Coupier, I., Frenay, M., Hopper, J. L., Daly, M. B., Terry, M. B., John, E. M., Buys, S. S., Yassin, Y., Miron, A., Goldgar, D., Singer, C. F., Tea, M. K., Pfeiler, G., Dressler, A. C., Hansen, T. O., Jonson, L., Ejlertsen, B., Barkardottir, R. B., Kirchhoff, T., Offit, K., Piedmonte, M., Rodriguez, G., Small, L., Boggess, J., Blank, S., Basil, J., Azodi, M., Toland, A. E., Montagna, M., Tognazzo, S., Agata, S., Imyanitov, E., Janavicius, R., Lazaro, C., Blanco, I., Pharoah, P. D., Sucheston, L., Karlan, B. Y., Walsh, C. S., Olah, E., Bozsik, A., Teo, S. H., Seldon, J. L., Beattie, M. S., van Rensburg, E. J., Sluiter, M. D., Diez, O., Schmutzler, R. K., Wappenschmidt, B., Engel, C., Meindl, A., Ruehl, I., Varon-Mateeva, R., Kast, K., Deissler, H., Niederacher, D., Arnold, N., Gadzicki, D., Schonbuchner, I., Caldes, T., de la Hoya, M., Nevanlinna, H., Aittomaki, K., Dumont, M., Chiquette, J., Tischkowitz, M., Chen, X., Beesley, J., Spurdle, A. B., Neuhausen, S. L., Chun Ding, Y., Fredericksen, Z., Wang, X., Pankratz, V. S., Couch, F., Simard, J., Easton, D. F., and Chenevix-Trench, G. Common Alleles at 6q25.1 and 1p11.2 Are Associated with Breast Cancer Risk for Brca1 and Brca2 Mutation Carriers. Hum Mol Genet, 20 (2011), 3304-21. [Pubmed Link]
  142. Broeks, A., Schmidt, M. K., Sherman, M. E., Couch, F. J., Hopper, J. L., Dite, G. S., Apicella, C., Smith, L. D., Hammet, F., Southey, M. C., Van 't Veer, L. J., de Groot, R., Smit, V. T., Fasching, P. A., Beckmann, M. W., Jud, S., Ekici, A. B., Hartmann, A., Hein, A., Schulz-Wendtland, R., Burwinkel, B., Marme, F., Schneeweiss, A., Sinn, H. P., Sohn, C., Tchatchou, S., Bojesen, S. E., Nordestgaard, B. G., Flyger, H., Orsted, D. D., Kaur-Knudsen, D., Milne, R. L., Perez, J. I., Zamora, P., Rodriguez, P. M., Benitez, J., Brauch, H., Justenhoven, C., Ko, Y. D., Hamann, U., Fischer, H. P., Bruning, T., Pesch, B., Chang-Claude, J., Wang-Gohrke, S., Bremer, M., Karstens, J. H., Hillemanns, P., Dork, T., Nevanlinna, H. A., Heikkinen, T., Heikkila, P., Blomqvist, C., Aittomaki, K., Aaltonen, K., Lindblom, A., Margolin, S., Mannermaa, A., Kosma, V. M., Kauppinen, J. M., Kataja, V., Auvinen, P., Eskelinen, M., Soini, Y., Chenevix-Trench, G., Spurdle, A. B., Beesley, J., Chen, X., Holland, H., Lambrechts, D., Claes, B., Vandorpe, T., Neven, P., Wildiers, H., Flesch-Janys, D., Hein, R., Loning, T., Kosel, M., Fredericksen, Z. S., Wang, X., Giles, G. G., Baglietto, L., Severi, G., McLean, C., Haiman, C. A., Henderson, B. E., Le Marchand, L., Kolonel, L. N., Alnaes, G. G., Kristensen, V., Borresen-Dale, A. L., Hunter, D. J., Hankinson, S. E., Andrulis, I. L., Mulligan, A. M., O'Malley, F. P., Devilee, P., Huijts, P. E., Tollenaar, R. A., Van Asperen, C. J., Seynaeve, C. S., Chanock, S. J., Lissowska, J., Brinton, L., Peplonska, B., Figueroa, J., Yang, X. R., Hooning, M. J., Hollestelle, A., Oldenburg, R. A., Jager, A., Kriege, M., Ozturk, B., van Leenders, G. J., Hall, P., Czene, K., Humphreys, K., Liu, J., Cox, A., Connley, D., Cramp, H. E., Cross, S. S., Balasubramanian, S. P., Reed, M. W., Dunning, A. M., Easton, D. F., Humphreys, M. K., Caldas, C., Blows, F., Driver, K., Provenzano, E., Lubinski, J., Jakubowska, A., Huzarski, T., Byrski, T., Cybulski, C., Gorski, B., Gronwald, J., Brennan, P., Sangrajrang, S., Gaborieau, V., Shen, C. Y., Hsiung, C. N., Yu, J. C., Chen, S. T., Hsu, G. C., Hou, M. F., Huang, C. S., Anton-Culver, H., Ziogas, A., Pharoah, P. D., and Garcia-Closas, M. Low Penetrance Breast Cancer Susceptibility Loci Are Associated with Specific Breast Tumor Subtypes: Findings from the Breast Cancer Association Consortium. Hum Mol Genet, 20 (2011), 3289-303. [Pubmed Link]
  143. Johnson, J., Healey, S., Khanna, K. K., and Chenevix-Trench, G. Mutation Analysis of Rad51l1 (Rad51b/Rec2) in Multiple-Case, Non-Brca1/2 Breast Cancer Families. Breast Cancer Res Treat, 129 (2011), 255-63. [Pubmed Link]
  144. Im, K. M., Kirchhoff, T., Wang, X., Green, T., Chow, C. Y., Vijai, J., Korn, J., Gaudet, M. M., Fredericksen, Z., Shane Pankratz, V., Guiducci, C., Crenshaw, A., McGuffog, L., Kartsonaki, C., Morrison, J., Healey, S., Sinilnikova, O. M., Mai, P. L., Greene, M. H., Piedmonte, M., Rubinstein, W. S., Hogervorst, F. B., Rookus, M. A., Collee, J. M., Hoogerbrugge, N., van Asperen, C. J., Meijers-Heijboer, H. E., Van Roozendaal, C. E., Caldes, T., Perez-Segura, P., Jakubowska, A., Lubinski, J., Huzarski, T., Blecharz, P., Nevanlinna, H., Aittomaki, K., Lazaro, C., Blanco, I., Barkardottir, R. B., Montagna, M., D'Andrea, E., Devilee, P., Olopade, O. I., Neuhausen, S. L., Peissel, B., Bonanni, B., Peterlongo, P., Singer, C. F., Rennert, G., Lejbkowicz, F., Andrulis, I. L., Glendon, G., Ozcelik, H., Toland, A. E., Caligo, M. A., Beattie, M. S., Chan, S., Domchek, S. M., Nathanson, K. L., Rebbeck, T. R., Phelan, C., Narod, S., John, E. M., Hopper, J. L., Buys, S. S., Daly, M. B., Southey, M. C., Terry, M. B., Tung, N., Hansen, T. V., Osorio, A., Benitez, J., Duran, M., Weitzel, J. N., Garber, J., Hamann, U., Peock, S., Cook, M., Oliver, C. T., Frost, D., Platte, R., Evans, D. G., Eeles, R., Izatt, L., Paterson, J., Brewer, C., Hodgson, S., Morrison, P. J., Porteous, M., Walker, L., Rogers, M. T., Side, L. E., Godwin, A. K., Schmutzler, R. K., Wappenschmidt, B., Laitman, Y., Meindl, A., Deissler, H., Varon-Mateeva, R., Preisler-Adams, S., Kast, K., Venat-Bouvet, L., Stoppa-Lyonnet, D., Chenevix-Trench, G., Easton, D. F., Klein, R. J., Daly, M. J., Friedman, E., Dean, M., Clark, A. G., Altshuler, D. M., Antoniou, A. C., Couch, F. J., Offit, K., and Gold, B. Haplotype Structure in Ashkenazi Jewish Brca1 and Brca2 Mutation Carriers. Hum Genet, (2011). [Pubmed Link]
  145. Beesley, J., Pickett, H. A., Johnatty, S. E., Dunning, A. M., Chen, X., Li, J., Michailidou, K., Lu, Y., Rider, D. N., Palmieri, R. T., Stutz, M. D., Lambrechts, D., Despierre, E., Lambrechts, S., Vergote, I., Chang-Claude, J., Nickels, S., Vrieling, A., Flesch-Janys, D., Wang-Gohrke, S., Eilber, U., Bogdanova, N., Antonenkova, N., Runnebaum, I. B., Dork, T., Goodman, M. T., Lurie, G., Wilkens, L. R., Matsuno, R. K., Kiemeney, L. A., Aben, K. K., Marees, T., Massuger, L. F., Fridley, B. L., Vierkant, R. A., Bandera, E. V., Olson, S. H., Orlow, I., Rodriguez-Rodriguez, L., Cook, L. S., Le, N. D., Brooks-Wilson, A., Kelemen, L. E., Campbell, I., Gayther, S. A., Ramus, S. J., Gentry-Maharaj, A., Menon, U., Ahmed, S., Baynes, C., Pharoah, P. D., Investigators, K., Muir, K., Lophatananon, A., Chaiwerawattana, A., Wiangnon, S., Macgregor, S., Easton, D. F., Reddel, R. R., Goode, E. L., and Chenevix-Trench, G. Functional Polymorphisms in the Tert Promoter Are Associated with Risk of Serous Epithelial Ovarian and Breast Cancers. PloS one, 6 (2011), e24987. [Pubmed Link]
  146. Mitra, A. V., Bancroft, E. K., Barbachano, Y., Page, E. C., Foster, C. S., Jameson, C., Mitchell, G., Lindeman, G. J., Stapleton, A., Suthers, G., Evans, D. G., Cruger, D., Blanco, I., Mercer, C., Kirk, J., Maehle, L., Hodgson, S., Walker, L., Izatt, L., Douglas, F., Tucker, K., Dorkins, H., Clowes, V., Male, A., Donaldson, A., Brewer, C., Doherty, R., Bulman, B., Osther, P. J., Salinas, M., Eccles, D., Axcrona, K., Jobson, I., Newcombe, B., Cybulski, C., Rubinstein, W. S., Buys, S., Townshend, S., Friedman, E., Domchek, S., Ramon, Y. C. T., Spigelman, A., Teo, S. H., Nicolai, N., Aaronson, N., Ardern-Jones, A., Bangma, C., Dearnaley, D., Eyfjord, J., Falconer, A., Gronberg, H., Hamdy, F., Johannsson, O., Khoo, V., Kote-Jarai, Z., Lilja, H., Lubinski, J., Melia, J., Moynihan, C., Peock, S., Rennert, G., Schroder, F., Sibley, P., Suri, M., Wilson, P., Bignon, Y. J., Strom, S., Tischkowitz, M., Liljegren, A., Ilencikova, D., Abele, A., Kyriacou, K., van Asperen, C., Kiemeney, L., Easton, D. F., and Eeles, R. A. Targeted Prostate Cancer Screening in Men with Mutations in Brca1 and Brca2 Detects Aggressive Prostate Cancer: Preliminary Analysis of the Results of the Impact Study. BJU international, 107 (2011), 28-39. [Pubmed Link]
  147. Osorio, A., Milne, R. L., Alonso, R., Pita, G., Peterlongo, P., Teule, A., Nathanson, K. L., Domchek, S. M., Rebbeck, T., Lasa, A., Konstantopoulou, I., Hogervorst, F. B., Verhoef, S., van Dooren, M. F., Jager, A., Ausems, M. G., Aalfs, C. M., van Asperen, C. J., Vreeswijk, M., Waisfisz, Q., Van Roozendaal, C. E., Ligtenberg, M. J., Easton, D. F., Peock, S., Cook, M., Oliver, C. T., Frost, D., Curzon, B., Evans, D. G., Lalloo, F., Eeles, R., Izatt, L., Davidson, R., Adlard, J., Eccles, D., Ong, K. R., Douglas, F., Downing, S., Brewer, C., Walker, L., Nevanlinna, H., Aittomaki, K., Couch, F. J., Fredericksen, Z., Lindor, N. M., Godwin, A., Isaacs, C., Caligo, M. A., Loman, N., Jernstrom, H., Barbany-Bustinza, G., Liljegren, A., Ehrencrona, H., Stenmark-Askmalm, M., Feliubadalo, L., Manoukian, S., Peissel, B., Zaffaroni, D., Bonanni, B., Fortuzzi, S., Johannsson, O. T., Chenevix-Trench, G., Chen, X. C., Beesley, J., Spurdle, A. B., Sinilnikova, O. M., Healey, S., McGuffog, L., Antoniou, A. C., Brunet, J., Radice, P., and Benitez, J. Evaluation of the Xrcc1 Gene as a Phenotypic Modifier in Brca1/2 Mutation Carriers. Results from the Consortium of Investigators of Modifiers of Brca1/Brca2. Br J Cancer, 104 (2011), 1356-61. [Pubmed Link]
  148. Thorne, H., Mitchell, G., and Fox, S. Kconfab: A Familial Breast Cancer Consortium Facilitating Research and Translational Oncology. Journal of the National Cancer Institute. Monographs, 2011 (2011), 79-81. [Pubmed Link]
  149. Chang, S., Wang, R. H., Akagi, K., Kim, K. A., Martin, B. K., Cavallone, L., Haines, D. C., Basik, M., Mai, P., Poggi, E., Isaacs, C., Looi, L. M., Mun, K. S., Greene, M. H., Byers, S. W., Teo, S. H., Deng, C. X., and Sharan, S. K. Tumor Suppressor Brca1 Epigenetically Controls Oncogenic Microrna-155. Nat Med, 17 (2011), 1275-82. [Pubmed Link]
  150. Berruti, A., Generali, D., Kaufmann, M., Puztai, L., Curigliano, G., Aglietta, M., Gianni, L., Miller, W. R., Untch, M., Sotiriou, C., Daidone, M., Conte, P., Kennedy, D., Damia, G., Petronini, P., Di Cosimo, S., Bruzzi, P., Dowsett, M., Desmedt, C., Mansel, R. E., Olivetti, L., Tondini, C., Sapino, A., Fenaroli, P., Tortora, G., Thorne, H., Bertolini, F., Ferrozzi, F., Danova, M., Tagliabue, E., de Azambuja, E., Makris, A., Tampellini, M., Dontu, G., Van't Veer, L., Harris, A. L., Fox, S. B., Dogliotti, L., and Bottini, A. International Expert Consensus on Primary Systemic Therapy in the Management of Early Breast Cancer: Highlights of the Fourth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2010). Journal of the National Cancer Institute. Monographs, 2011 (2011), 147-51. [Pubmed Link]
Familial Cancer Conference and Other Useful References
  1. Finkel. Australia takes a two-step approach on genetic studies. Science 280:1831-1832 (1998)
  2. Lindeman. G. on behalf of kConFab. Outclassing ‘Kath and Kim’ – an Aussie kith and kin cancer conference. Meeting report on “Familial Cancer 2003 – Research and Practice” Couran Cove, Queensland, September 2003 Cancer Forum November 2003
  3. Lindeman. G. on behalf of kConFab. Meeting report on “Familial Cancer 2003 – Research and Practice” Couran Cove, Queensland, September 2003 Biomed Central February 2004
  4. A combined meeting of kConFab, AOCS, ACCFS and the Family Cancer Clinics of Australia and New Zealand September 2005. Hereditary Cancer in Clinical Practice. Vol 3.4 2005 S1-37
  5. Someone rings you wanting their kConFab mutation test result - what does this mean? Mary Anne Young and Heather Thorne on behalf of the kConFab consortium. July 2006 edition of LINKAGE
  6. Catchpoole, D., deFazio, A., Devereux, L., Fleming, M., Hof, M., Schmidt, C., Thorne, H., Zeps, N. The importance of biosrepository networks: the Australiasian Biospecimen Network - Oncology. Australian Journal of Medical Science 28(1): 16-20 (2007)
  7. EA Lobb, K Barlow-Stewart, G Suthers and N Hallowell Treatment-focused DNA testing for newly diagnosed breast cancer patients: some implications for clinical practice. Clinical Genetics 2009

The information provided on the kConFab Home Page is for information only, and is not a substitute for talking to a health professional.